Anogenital herpesviral [herpes simplex] infection

AB1_ANOGENITAL_HERPES_SIMPLEX_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A60 Hospital discharge: ICD-10 — A60 Hospital discharge: ICD-9 — 0541A Hospital discharge: ICD-8 — 5402 Cause of death: ICD-10 — A60 Cause of death: ICD-9 — 0541A Cause of death: ICD-8 — 5402 3 out of 7 registries used, show all original rules.	5054
4. Check minimum number of events None	5054
5. Include endpoints None	5054
6. Filter based on genotype QC (FinnGen only)	4806

Control definitions (FinnGen only)

Control exclude: AB1_SEXUAL_TRANSMISSION

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF13

NAME	AB1_ANOGENITAL_HERPES_SIMPLEX_WIDE
CONTROL_EXCLUDE	AB1_SEXUAL_TRANSMISSION
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A60
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A60
HD_ICD_9	0541A
HD_ICD_8	5402
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A60
COD_ICD_9	0541A
COD_ICD_8	5402
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anogenital herpesviral [herpes simplex] infection based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Anogenital herpesviral [herpes simplex] infection

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4806	3806	1000
Unadjusted period prevalence (%)	1.16	1.35	0.46
Median age at first event (years)	35.13	32.86	43.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5054: Matched controls
50540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N51.8*A60.0

ICD-10 Finland

Herpes simplex infection of the genitals in men

103.2

310.1

160

A63.0

ICD-10 Finland

Anogenital (venereal) warts

16.6

307.7

548

368

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

+∞

307.7

4060

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

74.5

307.7

540

N77.1

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

12.5

307.7

339

288

J05AB11

ATC

valaciclovir; oral

14.3

307.7

2703

3749

A60.9

ICD-10 Finland

Anogenital herpesviral infection, unspecified

+∞

307.7

363

X90

ICPC

Genital herpes female

34.4

307.7

289

J05AB01

ATC

aciclovir; systemic

15.6

307.7

3546

6608

D06BB03

ATC

aciclovir; topical

7.1

307.7

615

974

N77.0*A60.0

ICD-10 Finland

Ulceration of vulva in herpesviral [herpes simplex] infection

54.5

307.7

259

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

13.9

307.7

356

275

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

6.3

307.7

1176

2334

N76.0

ICD-10 Finland

Acute vaginitis

3.0

168.9

891

3388

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

13.6

159.9

150

113

J02AC01

ATC

fluconazole; systemic

2.2

159.1

2655

16947

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

9.0

159.1

199

229

X23

ICPC

Fear sexually transm dis female

2.9

157.2

866

3362

N51.8

ICD-10 Finland

Other disorders of male genital organs in diseases classified elsewhere

+∞

114.0

109

Y72

ICPC

Genital herpes male

54.0

112.3

N77.0

ICD-10 Finland

Ulceration of vulva in infectious and parasitic diseases classified elsewhere

135.4

111.6

119

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

109.0

1802

11023

P01AB01

ATC

metronidazole; oral, rectal

1.9

106.6

2243

14853

A60

ICD-10 Finland

Anogenital herpesviral [herpes simplex] infection

+∞

104.5

100

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

4.8

96.6

224

484

A60.1

ICD-10 Finland

Herpesviral infection of perianal skin and rectum

+∞

95.1

0541A

ICD-9 Finland

Herpes simplex, Genital herpes[HERPES GENITALIS PRIMARIUS]

+∞

95.1

O98.3

ICD-10 Finland

Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium

41.2

94.2

D06BB04

ATC

podophyllotoxin; topical

2.9

91.8

483

1804

Z2221

NOMESCO Finland

Medical doctor

1.9

86.1

1527

9410

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

85.9

2193

15115

Y25

ICPC

Fear sexually transm disease male

5.0

85.4

186

381

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

9.4

84.6

101

109

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

83.5

1615

10212

N06AX11

ATC

mirtazapine; oral

1.8

82.9

1761

11455

Z71.8

ICD-10 Finland

Other specified counselling

1.8

82.7

1929

12902

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

3.3

81.4

331

1065

B00.0

ICD-10 Finland

Eczema herpeticum

9.7

77.2

N48.1

ICD-10 Finland

Balanoposthitis

5.9

77.2

141

246

A56.3

ICD-10 Finland

Chlamydial infection of anus and rectum

26.8

77.2

S71

ICPC

Herpes simplex

7.3

77.0

114

160

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

4.0

75.2

223

582

N30.0

ICD-10 Finland

Acute cystitis

2.0

72.6

985

5506

N76.6

ICD-10 Finland

Ulceration of vulva

6.3

70.6

120

195

Z3231

NOMESCO Finland

Registered nurse

1.8

69.8

1257

7697

B00

ICD-10 Finland

Herpesviral [herpes simplex] infections

12.5

69.3

ULA02

NOMESCO Finland

Kolposcopy

2.1

69.0

715

3617

J05AB09

ATC

famciclovir; oral

10.3

68.8

N05BA04

ATC

oxazepam; oral

1.8

67.9

1358

8573

X15

ICPC

Vaginal symptom/complaint other

2.6

67.9

426

1733

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

65.6

3317

26773

M79.6

ICD-10 Finland

Pain in limb

1.7

63.2

2071

14908

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

14.9

63.1

J01EA01

ATC

trimethoprim; systemic

1.8

62.5

1359

8756

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

62.1

1114

6781

J01MA02

ATC

ciprofloxacin; systemic

1.7

60.5

1569

10594

N02AX02

ATC

tramadol; systemic, rectal

1.7

60.5

1734

12023

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.3

60.2

494

2267

N05AH04

ATC

quetiapine; oral

1.8

58.6

1096

6740

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

58.6

947

5569

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

57.9

752

4112

J01CA08

ATC

pivmecillinam; oral

1.6

57.4

2370

17925

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

4.1

57.2

160

400

D11

ICPC

Diarrhoea

1.9

56.7

841

4806

D06BB10

ATC

imiquimod; topical

2.9

55.5

279

1011

J01DB01

ATC

cefalexin; oral

1.8

54.7

4226

37152

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

54.4

1900

13752

N05CF02

ATC

zolpidem; oral

1.9

54.1

872

5110

U02

ICPC

Urinary frequency/urgency

1.9

54.0

743

4138

R4110

NOMESCO Finland

Physiotherapy

1.7

53.6

1125

7128

N06AB04

ATC

citalopram; systemic

1.8

53.3

1009

6206

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

52.6

672

3646

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

52.1

908

5445

R74

ICPC

Upper respiratory infection acute

1.6

51.6

2233

16929

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

3.0

51.0

240

838

S29

ICPC

Skin symptom/complaint other

1.8

51.0

897

5391

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

50.9

1288

8569

R21

ICPC

Throat symptom/complaint

1.6

50.6

1651

11702

X14

ICPC

Vaginal discharge

2.7

50.6

274

1032

X92

ICPC

Chlamydia infection genital female

3.1

47.8

204

674

R53

ICD-10 Finland

Malaise and fatigue

1.6

47.4

1272

8565

U01

ICPC

Dysuria/painful urination

2.1

47.1

498

2520

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

46.9

1065

6863

M03BX02

ATC

tizanidine; oral

1.5

46.3

3062

25245

G01AA10

ATC

clindamycin; vaginal

1.8

46.3

856

5208

ZXE00

NOMESCO Finland

One hour or less

1.6

45.8

1866

13845

N03AX16

ATC

[U] pregabalin

1.7

45.6

918

5721

Z01.2

ICD-10 Finland

Dental examination

1.5

43.7

2532

20187

N30

ICD-10 Finland

Cystitis

2.0

43.6

538

2874

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

43.0

749

4470

R30.0

ICD-10 Finland

Dysuria

2.6

43.0

269

1089

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.8

42.8

720

4252

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

42.6

835

5153

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

42.5

1564

11300

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

42.1

1550

11194

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

41.7

1991

15200

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

41.4

979

6352

N05CF01

ATC

zopiclone; oral

1.6

41.4

1194

8144

U13

ICPC

Bladder symptom/complaint other

3.3

41.4

158

488

M54.5

ICD-10 Finland

Low back pain

1.5

41.2

1836

13808

R51.80

ICD-10 Finland

Headache

1.7

41.2

984

6403

N06AB10

ATC

escitalopram; oral

1.6

40.6

1320

9253

J01MA06

ATC

norfloxacin; oral

1.9

40.3

538

2949

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

39.8

2008

15461

J01AA02

ATC

doxycycline; systemic

1.5

39.8

3393

29027

J01FA10

ATC

azithromycin; systemic

1.5

39.5

3154

26600

Z3226

NOMESCO Finland

Physiotherapist

1.7

39.2

745

4551

A02BC02

ATC

pantoprazole; systemic

1.5

39.2

2862

23692

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

38.9

333

1548

N76.2

ICD-10 Finland

Acute vulvitis

5.5

38.9

138

X16

ICPC

Vulval symptom/complaint

3.2

38.4

158

511

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.0

38.1

467

2486

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

37.9

705

4277

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

37.8

3890

34413

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

37.8

950

6247

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

37.6

1167

8071

C05AA08

ATC

fluocortolone; rectal, topical

1.9

36.4

516

2882

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

36.2

844

5438

M25.5

ICD-10 Finland

Pain in joint

1.5

36.1

1573

11694

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

11.6

36.0

N06AX21

ATC

duloxetine; oral

1.8

35.7

599

3522

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

35.5

1059

7245

D01

ICPC

Abdominal pain/cramps general

1.7

35.3

718

4458

T74.1

ICD-10 Finland

Physical abuse

2.9

35.3

167

585

L17

ICPC

Foot/toe symptom/complaint

1.5

35.2

1229

8710

U71

ICPC

Cystitis/urinary infection other

2.1

35.1

362

1809

M79.1

ICD-10 Finland

Myalgia

1.7

34.9

805

5167

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

34.8

956

6408

N02BE01

ATC

paracetamol; systemic, rectal

1.6

34.8

4231

38380

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

34.8

1166

8185

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

34.8

900

5947

R51

ICD-10 Finland

Headache

2.0

34.3

391

2026

M01AB05

ATC

diclofenac; systemic, rectal

1.4

34.0

2958

24989

G44.2

ICD-10 Finland

Tension-type headache

1.7

33.8

793

5108

C07AA05

ATC

propranolol; systemic

1.6

33.8

1117

7811

N05BA01

ATC

diazepam; systemic, rectal

1.8

33.6

521

2989

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

33.4

717

4513

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

33.4

482

2704

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.5

33.3

222

925

N87.0

ICD-10 Finland

Mild cervical dysplasia

2.6

33.3

196

770

L29.2

ICD-10 Finland

Pruritus vulvae

3.1

33.2

142

470

U07

ICPC

Urine symptom/complaint other

2.2

33.1

298

1414

N06AX16

ATC

venlafaxine; oral

1.6

33.0

819

5350

H00.00

ICD-10 Finland

Hordeolum

2.2

32.9

277

1278

L03

ICPC

Low back symptom/complaint

1.5

32.9

1385

10187

E0000UV, ,

ATC

1.4

32.8

2063

16390

R52.9

ICD-10 Finland

Pain, unspecified

1.9

32.6

460

2562

J01FF01

ATC

clindamycin; systemic

1.5

32.5

1152

8169

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

32.2

614

3739

Z2446

NOMESCO Finland

Social worker

2.1

31.9

339

1712

P01

ICPC

Feeling anxious/nervous/tense

1.6

31.9

1039

7228

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

8.4

31.7

J01MA12

ATC

levofloxacin; systemic

1.7

31.6

609

3720

L12

ICPC

Hand/finger symptom/complaint

1.6

31.5

806

5300

Z01.7

ICD-10 Finland

Laboratory examination

1.7

31.4

698

4428

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

31.4

632

3905

N01

ICPC

Headache

1.6

31.3

828

5489

Z29.2

ICD-10 Finland

Other prophylactic chemotherapy

9.8

31.2

N06AB03

ATC

fluoxetine; oral

1.7

31.0

599

3660

EB1AA, ,

SPAT

2.0

30.7

358

1869

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

30.3

1359

10092

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

30.3

865

5834

L01

ICPC

Neck symptom/complaint

1.6

30.1

819

5459

M54

ICD-10 Finland

Dorsalgia

1.7

30.0

691

4422

R03AC02

ATC

salbutamol; inhalant

1.4

29.8

2703

22761

J02AC02

ATC

itraconazole; systemic

1.6

29.6

733

4776

LCH11

NOMESCO Finland

Pharmacologic abortion

1.9

29.5

392

2140

A02BC05

ATC

esomeprazole; systemic

1.4

29.5

1615

12445

A54.6

ICD-10 Finland

Gonococcal infection of anus and rectum

+∞

29.2

A51.0

ICD-10 Finland

Primary genital syphilis

+∞

29.2

M01AH05

ATC

etoricoxib; oral

1.4

29.1

2743

23208

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

28.9

504

2988

R05

ICPC

Cough

1.5

28.6

1163

8452

R07.3

ICD-10 Finland

Other chest pain

1.9

28.6

403

2241

A56.2

ICD-10 Finland

Chlamydial infection of genitourinary tract, unspecified

6.5

28.5

N06AX26

ATC

vortioxetine; oral

1.8

28.4

472

2761

R50.9

ICD-10 Finland

Fever, unspecified

1.6

28.3

676

4362

WX110, ,

SPAT

2.0

28.3

340

1794

P06

ICPC

Sleep disturbance

1.6

28.2

646

4123

F32

ICD-10 Finland

Depressive episode

1.9

28.1

383

2106

N76

ICD-10 Finland

Other inflammation of vagina and vulva

3.1

28.1

118

387

LEB00

NOMESCO Finland

Biopsy of vagina

3.5

27.9

273

H01.0

ICD-10 Finland

Blepharitis

1.9

27.7

376

2065

N06AB06

ATC

sertraline; oral

1.6

27.5

667

4316

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

27.4

1220

9015

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

27.1

277

1378

J20

ICD-10 Finland

Acute bronchitis

1.8

27.1

465

2744

EB1SA, ,

SPAT

1.9

27.1

330

1749

J01FA06

ATC

roxithromycin; oral

1.4

27.0

1668

13080

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

27.0

232

1080

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

26.9

598

3787

SDA03

NOMESCO Finland

Periodontal treatment

1.4

26.8

2042

16588

WX002

NOMESCO Finland

Sedation and analgesia

1.6

26.8

650

4207

J01DA01

ATC

[U] cefalexin

1.4

26.6

2840

24355

S18

ICPC

Laceration/cut

1.4

26.6

1694

13350

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.5

26.5

263

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.1

26.2

259

1273

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

2.2

26.1

232

1094

P74

ICPC

Anxiety disorder/anxiety state

1.9

26.0

349

1909

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.6

25.9

149

579

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

25.9

480

2894

Y04

ICPC

Penis symptom/complaint other

7.0

25.8

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

25.8

368

2053

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

25.7

412

2382

R42

ICD-10 Finland

Dizziness and giddiness

1.5

25.7

825

5695

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

25.6

167

689

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

25.5

451

2684

S21

ICPC

Skin texture symptom/complaint

1.6

25.4

574

3645

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.5

25.3

1005

7246

A54.0

ICD-10 Finland

Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

35.8

25.2

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

25.1

313

1670

R06AE07

ATC

cetirizine; oral

1.4

25.1

2263

18821

R06.0

ICD-10 Finland

Dyspnoea

1.5

25.1

934

6647

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

24.8

784

5389

S06.0

ICD-10 Finland

Concussion

1.7

24.8

515

3201

K08.80

ICD-10 Finland

Toothache NOS

1.7

24.7

510

3164

N05BA12

ATC

alprazolam; oral

1.8

24.7

406

2365

X29

ICPC

Genital sympt/compl female other

2.8

24.3

124

453

B00.8

ICD-10 Finland

Other forms of herpesviral infection

20.1

24.3

R06AX27

ATC

desloratadine; oral

1.4

24.1

1624

12865

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.6

24.1

142

559

AA1AD

NOMESCO Finland

CT of head and brain

1.5

24.1

766

5270

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

24.0

204

945

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

24.0

1439

11178

UJH02

NOMESCO Finland

Anoscopy

2.4

23.9

167

712

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

23.8

811

5662

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

23.8

967

6997

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

23.7

1033

7572

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

23.7

481

2971

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

23.6

2694

23149

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

23.5

3645

32847

L82

ICD-10 Finland

Seborrhoeic keratosis

1.6

23.5

547

3499

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

23.4

276

1446

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

23.4

1818

14723

A04

ICPC

Weakness/tiredness general

1.5

23.3

738

5067

M01AE02

ATC

naproxen; oral, rectal

1.3

23.2

2820

24437

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

23.1

2375

20063

A11

ICPC

Chest pain NOS

2.0

22.9

271

1421

R83

ICPC

Respiratory infection other

1.4

22.7

1681

13493

A54.5

ICD-10 Finland

Gonococcal pharyngitis

120.6

22.6

L02

ICPC

Back symptom/complaint

1.6

22.5

545

3519

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

22.4

419

2529

A97

ICPC

No disease

1.5

22.4

810

5719

R35

ICD-10 Finland

Polyuria

2.1

22.3

204

974

A03

ICPC

Fever

1.4

22.2

1048

7788

F29

ICPC

Eye symptom/complaint other

1.7

22.2

430

2622

K03.00

ICD-10 Finland

Approximal wear

1.8

22.0

362

2106

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

22.0

302

1663

D10

ICPC

Vomiting

1.7

22.0

468

2925

U72

ICPC

Urethritis

2.6

22.0

131

519

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

21.9

346

1991

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

21.9

341

1954

H02AB07

ATC

prednisone; oral

1.7

21.5

467

2934

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

21.4

433

2670

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

21.1

1593

12787

XKD00

NOMESCO Finland

Uroflowmetry

1.8

21.1

299

1663

D06AX01

ATC

fusidic acid; topical

1.7

21.0

458

2877

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

21.0

378

2257

A01

ICPC

Pain general/multiple sites

1.7

21.0

372

2212

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

20.9

427

2638

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

20.9

789

5611

R07.0

ICD-10 Finland

Pain in throat

1.7

20.9

445

2780

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

20.9

3667

33304

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

20.7

3056

27023

D07AC01

ATC

betamethasone; topical

1.4

20.7

1470

11683

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.9

20.6

290

1609

UKC02

NOMESCO Finland

Cystoscopy

1.7

20.5

372

2225

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

20.5

288

1598

R01AD09

ATC

mometasone; nasal

1.3

20.4

2311

19662

N06BA04

ATC

methylphenidate; oral

1.9

20.4

284

1571

ZY010

NOMESCO Finland

Hospital outpatient

1.8

20.3

318

1823

SPAT1324

SPAT

Screening procedure

0.6

20.2

553

8072

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

20.2

2584

22351

D06

ICPC

Abdominal pain localized other

1.6

20.2

464

2954

P03

ICPC

Feeling depressed

1.5

20.2

709

4967

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.8

20.1

319

1838

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.1

20.1

192

933

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

19.9

455

2893

F51

ICD-10 Finland

Nonorganic sleep disorders

1.9

19.8

270

1484

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

19.7

276

1529

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

19.6

1383

10962

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

19.6

549

3664

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

19.5

418

2616

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

19.5

406

2522

A02BC03

ATC

lansoprazole; oral

1.4

19.4

920

6821

H02AB06

ATC

prednisolone; systemic

1.3

19.4

1872

15537

Y29

ICPC

Genital symptom/complaint male other

6.1

19.4

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.7

19.3

100

369

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

19.3

313

1813

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.3

19.3

143

626

H57.1

ICD-10 Finland

Ocular pain

2.0

19.3

210

1070

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

19.2

771

5540

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

19.2

286

1615

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

19.2

1266

9921

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

19.1

1754

14444

N01BB02

ATC

lidocaine; parenteral

4.5

19.1

103

K02.1

ICD-10 Finland

Caries of dentine

1.3

19.1

3136

27985

N17

ICPC

Vertigo/dizziness

1.6

18.8

440

2813

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

18.8

892

6613

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

18.7

516

3427

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

18.7

1995

16764

H92.0

ICD-10 Finland

Otalgia

1.7

18.6

340

2038

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

6.1

18.6

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

18.5

197

996

H01

ICPC

Ear pain/earache

1.5

18.4

649

4545

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.2

18.4

157

730

D07AD01

ATC

clobetasol; topical

1.5

18.2

616

4275

WW200

NOMESCO Finland

Immunization

2.4

18.2

125

530

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

18.2

360

2206

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.9

18.2

224

1192

I84

ICD-10 Finland

Hemorrhoids

2.5

18.1

113

458

ZXD20

NOMESCO Finland

Day surgery

1.6

18.1

505

3365

R00.2

ICD-10 Finland

Palpitations

1.7

18.0

382

2381

G01AF04

ATC

miconazole; vaginal

2.0

17.9

201

1035

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.2

17.8

142

642

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

17.8

575

3953

KMAK, ,

NOMESCO Finland

1.3

17.8

2697

23697

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

17.8

391

2461

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

17.7

409

2604

N03AX12

ATC

[U] gabapentin; oral

1.5

17.7

583

4023

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

1.8

17.7

259

1456

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

17.7

473

3121

L08

ICPC

Shoulder symptom/complaint

1.4

17.6

774

5652

B86

ICD-10 Finland

Scabies

2.1

17.6

168

816

F43.0

ICD-10 Finland

Acute stress reaction

1.6

17.5

394

2493

KGD10

NOMESCO Finland

Destruction of lesion of penis

180.6

17.5

X58

ICD-10 Finland

Exposure to other specified factors

1.5

17.5

641

4523

N03AE01

ATC

clonazepam; systemic

1.9

17.4

212

1124

N03AX09

ATC

lamotrigine; oral

1.7

17.3

310

1848

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

17.2

282

1640

G01AF05

ATC

econazole; vaginal

1.7

17.2

331

2013

P19

ICPC

Drug abuse

3.0

17.0

259

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

16.9

219

1185

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

16.8

373

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

16.8

669

4793

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

16.8

963

7358

R05

ICD-10 Finland

Cough

1.4

16.7

864

6487

R03BA02

ATC

budesonide; inhalant

1.4

16.7

775

5712

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

16.6

4573

43573

SFA20

NOMESCO Finland

Two-surface restoration

1.3

16.6

2936

26202

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

16.6

216

1171

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

16.5

464

3093

A02BC01

ATC

omeprazole; systemic

1.4

16.5

1000

7707

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.3

16.5

123

541

N94.1

ICD-10 Finland

Dyspareunia

2.2

16.5

131

592

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

16.5

355

2223

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

16.4

527

3615

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

16.4

370

2342

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.9

16.4

224

1232

L05

ICPC

Flank/axilla symptom/complaint

1.8

16.3

233

1300

P02

ICPC

Acute stress reaction

1.6

16.3

382

2443

X72

ICPC

Genital candidiasis female

2.4

16.2

111

470

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

2.3

16.2

123

545

N87.1

ICD-10 Finland

Moderate cervical dysplasia

2.2

16.2

141

661

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

16.2

396

2557

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

16.1

1060

8271

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.1

16.1

149

716

R12

ICD-10 Finland

Heartburn

1.6

16.1

357

2252

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.9

16.1

199

1061

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.8

16.0

268

1567

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

16.0

360

2279

Z00.0

ICD-10 Finland

General medical examination

1.4

16.0

821

6156

R2110

NOMESCO Finland

Giving the first information

1.7

16.0

332

2060

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

15.9

829

6227

K30

ICD-10 Finland

Functional dyspepsia

1.5

15.9

487

3308

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

15.9

3525

32292

H10

ICD-10 Finland

Conjunctivitis

1.6

15.8

419

2755

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

15.8

335

2087

A01AB09

ATC

miconazole; local oral

1.7

15.8

292

1755

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

15.7

218

1205

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

2.0

15.7

159

790

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

15.7

375

2408

SFA10

NOMESCO Finland

One-surface restoration

1.3

15.6

2778

24716

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

26.3

15.6

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

15.6

399

2605

J02

ICD-10 Finland

Acute pharyngitis

1.7

15.5

288

1735

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

15.5

354

2249

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

15.5

731

5399

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

15.5

1603

13329

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.5

15.3

533

3716

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

15.3

168

860

N05CD07

ATC

temazepam; oral

1.8

15.3

243

1401

Z00.8

ICD-10 Finland

Other general examinations

1.6

15.1

362

2325

R11

ICD-10 Finland

Nausea and vomiting

1.6

15.1

401

2638

WX290, ,

SPAT

1.8

15.1

209

1155

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

15.1

391

2558

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

15.1

288

1747

W79

ICPC

Unwanted pregnancy

2.0

15.0

158

796

U05

ICPC

Urination problems other

2.1

15.0

141

682

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

14.9

202

1109

K62.6

ICD-10 Finland

Ulcer of anus and rectum

3.2

14.9

183

ZXD05

NOMESCO Finland

Urgent procedure

1.3

14.8

1363

11139

G04CA02

ATC

tamsulosin; oral

1.6

14.8

344

2193

K59.0

ICD-10 Finland

Constipation

1.9

14.8

195

1061

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

14.8

500

3467

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

14.7

380

2484

D19

ICPC

Teeth/gum symptom/complaint

1.3

14.7

1414

11623

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

14.7

698

5159

Z21

ICD-10 Finland

Asymptomatic human immunodeficiency virus [HIV] infection status

13.2

14.7

G01AF01

ATC

metronidazole; vaginal

1.6

14.6

315

1971

X01

ICPC

Genital pain female

2.5

14.6

346

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

+∞

14.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

14.5

296

1827

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

14.5

133

637

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

14.4

196

1077

U29

ICPC

Urinary symptom/complaint other

2.4

14.4

102

439

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

4.1

14.4

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.1

14.4

130

619

J03

ICD-10 Finland

Acute tonsillitis

1.8

14.4

203

1129

J01CA04

ATC

amoxicillin; systemic

1.4

14.4

4190

39494

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

3.4

14.3

152

D09

ICPC

Nausea

1.6

14.3

300

1865

P29

ICPC

Psychological sympt/compl other

1.5

14.3

472

3255

A05

ICPC

Feeling ill

1.5

14.3

393

2608

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

14.2

157

805

N06AX12

ATC

bupropion; oral

1.5

14.2

447

3051

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

14.2

554

3947

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

14.2

366

2392

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

14.2

1405

11585

R02

ICPC

Shortness of breath/dyspnoea

1.5

14.2

457

3136

E000006, ,

ATC

1.7

14.2

262

1576

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

1.9

14.1

190

1041

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

14.1

380

2509

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.5

14.1

358

WX290

NOMESCO Finland

Other blockage of nerve

1.3

14.1

2644

23547

D73

ICPC

Gastroenteritis presumed infection

1.7

14.0

242

1428

SPAT1283

SPAT

Restricted health certificate

1.3

14.0

1295

10580

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

13.9

903

7016

ZXA00

NOMESCO Finland

Right side

1.4

13.9

717

5371

N06AX05

ATC

trazodone; oral

2.1

13.9

129

622

SPAT1192

SPAT

Gynaecological examination

1.4

13.8

805

6148

N06AX03

ATC

mianserin; oral

2.0

13.8

154

794

X84

ICPC

Vaginitis/vulvitis NOS

2.6

13.8

297

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

13.7

567

4086

B34.9

ICD-10 Finland

Viral infection, unspecified

1.9

13.7

172

923

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

13.6

230

1349

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

13.6

1015

8044

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

13.6

418

2839

D07AC13

ATC

mometasone; topical

1.3

13.6

1162

9386

S04

ICPC

Lump/swelling localized

1.5

13.6

471

3280

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

13.5

1383

11437

J01AA04

ATC

lymecycline; systemic

1.4

13.5

715

5376

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

13.4

293

1840

L15

ICPC

Knee symptom/complaint

1.3

13.4

869

6749

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

13.3

243

1456

K07.60

ICD-10 Finland

Snapping jaw

1.6

13.3

313

2001

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

13.3

212

1224

Z2445

NOMESCO Finland

Psychologist

1.7

13.3

222

1299

GD1AA, ,

SPAT

1.4

13.3

617

4538

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

13.3

817

6292

UJF32

NOMESCO Finland

Coloscopy

1.4

13.3

737

5585

A99

ICPC

Disease/condition unspecnature/site

1.6

13.2

336

2188

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.7

13.2

234

1391

N06AA09

ATC

amitriptyline; systemic

1.7

13.2

261

1599

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

13.2

245

1477

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

13.1

210

1213

L10

ICPC

Elbow symptom/complaint

1.7

13.1

233

1387

XLA10, ,

NOMESCO Finland

1.8

13.1

182

1008

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

13.1

213

1237

M02AA07

ATC

piroxicam; topical

1.3

13.1

1058

8476

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.4

13.1

662

4939

N03AG01

ATC

valproic acid; systemic, rectal

1.7

13.1

254

1549

N06AB05

ATC

paroxetine; oral

1.7

13.0

261

1604

G43

ICD-10 Finland

Migraine

1.5

13.0

397

2692

A98

ICPC

Health maint/preventive medicine

2.3

13.0

4971

48687

R33

ICD-10 Finland

Retention of urine

2.0

13.0

148

768

M79.7

ICD-10 Finland

Fibromyalgia

1.9

13.0

175

961

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

5.2

12.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

12.9

231

1377

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

12.9

1319

10898

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

2.8

12.9

216

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

12.7

122

595

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.5

12.7

333

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

12.7

647

4832

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

12.7

474

3349

A02BA02

ATC

ranitidine; systemic

1.4

12.6

502

3591

R01AD08

ATC

fluticasone; nasal

1.3

12.5

1326

10997

G03HB01

ATC

cyproterone and estrogen; oral

1.4

12.5

673

5071

F31

ICD-10 Finland

Bipolar affective disorder

2.4

12.5

342

N89.0

ICD-10 Finland

Mild vaginal dysplasia

5.2

12.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

12.4

486

3464

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

12.4

165

903

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

12.3

1188

9732

G50.1

ICD-10 Finland

Atypical facial pain

2.4

12.3

326

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.5

12.3

360

2420

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

12.3

883

6950

D06BX01

ATC

metronidazole; topical

1.5

12.2

435

3043

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

1.8

12.2

173

964

S02

ICPC

Pruritus

1.8

12.2

176

986

ZXA10

NOMESCO Finland

Bilateral

1.4

12.2

559

4097

N05AH03

ATC

olanzapine; systemic

1.6

12.2

298

1923

H93.1

ICD-10 Finland

Tinnitus

1.7

12.2

232

1408

R4120

NOMESCO Finland

Occupational therapy

1.7

12.2

231

1401

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

12.1

193

1114

L30

ICD-10 Finland

Other dermatitis

2.1

12.1

117

573

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

12.1

229

1387

H02AB04

ATC

methylprednisolone; systemic

1.4

12.1

477

3404

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

12.0

604

4497

H29

ICPC

Ear symptom/complaint other

1.5

12.0

382

2613

J01AA07

ATC

tetracycline; systemic

1.3

12.0

758

5853

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

12.0

859

6756

N64.4

ICD-10 Finland

Mastodynia

1.7

12.0

197

1148

B02.9

ICD-10 Finland

Zoster without complication

1.8

12.0

179

1015

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

12.0

651

4912

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.3

11.9

1022

8242

Z72.2

ICD-10 Finland

Drug use

3.0

11.8

166

O04.0

ICD-10 Finland

Medical abortion, incomplete, complicated by genital tract and pelvic infection

3.5

11.8

116

L08.0

ICD-10 Finland

Pyoderma

3.0

11.7

167

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

11.7

151

818

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

11.6

151

820

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

11.6

910

7246

A06AC51

ATC

ispaghula, combinations; oral

1.8

11.6

163

907

M54.2

ICD-10 Finland

Cervicalgia

1.5

11.6

336

2254

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

11.6

239

1482

M54.8

ICD-10 Finland

Other dorsalgia

1.7

11.5

202

1199

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.7

11.5

211

1268

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

11.5

233

1438

B37.2

ICD-10 Finland

Candidiasis of skin and nail

3.7

11.5

N06AB08

ATC

fluvoxamine; oral

2.2

11.4

439

Z30

ICD-10 Finland

Contraceptive management

1.7

11.4

205

1225

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

11.4

165

927

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

11.4

152

833

TAB00

NOMESCO Finland

Lumbar puncture

1.7

11.4

195

1151

N90.0

ICD-10 Finland

Mild vulvar dysplasia

5.4

11.3

N07BB01

ATC

disulfiram; oral

1.8

11.3

158

878

J01

ICD-10 Finland

Acute sinusitis

1.5

11.3

302

1991

N48.8

ICD-10 Finland

Other specified disorders of penis

4.9

11.2

W83

ICPC

Abortion induced

2.4

11.1

311

R06AX22

ATC

ebastine; oral

1.3

11.1

778

6094

M54.3

ICD-10 Finland

Sciatica

1.7

11.1

208

1257

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

11.1

415

2931

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

11.1

323

2170

R01AD58

ATC

fluticasone, combinations; nasal

1.3

11.1

1336

11225

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

11.1

1081

8854

-1, ,

NOMESCO Finland

1.2

11.0

1737

15031

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

11.0

1189

9856

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

11.0

330

2230

SAA01, ,

SPAT

2.9

11.0

168

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

3.9

11.0

XQ800

NOMESCO Finland

Prick test

1.5

11.0

393

2753

E000001, ,

ATC

1.3

10.9

914

7335

R60.0

ICD-10 Finland

Localized oedema

1.5

10.9

323

2176

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

10.9

501

3672

R01AD12

ATC

fluticasone furoate; nasal

1.2

10.9

1683

14528

SPAT1240

SPAT

Therapeutic discussion

1.3

10.9

674

5184

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

10.9

1068

8750

A01AB04

ATC

amphotericin B; local oral

2.1

10.9

104

508

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

10.9

242

1529

A02BC04

ATC

rabeprazole; oral

1.5

10.9

331

2245

B02

ICD-10 Finland

Zoster [herpes zoster]

1.8

10.9

146

802

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.3

10.9

352

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

10.8

155

868

N76.5

ICD-10 Finland

Ulceration of vagina

3.7

10.8

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.4

10.8

490

3585

L28

ICPC

Limited function/disability (L)

1.4

10.7

413

2934

WX892

NOMESCO Finland

Monitored bed care

1.7

10.7

210

1285

J45

ICD-10 Finland

Asthma

1.4

10.7

430

3078

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

10.7

181

1065

H00.1

ICD-10 Finland

Chalazion

1.8

10.7

160

909

J01MA01

ATC

ofloxacin; systemic

1.7

10.7

210

1287

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.1

10.6

479

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.2

10.6

414

R03AC03

ATC

terbutaline; inhalant

1.4

10.6

564

4240

D12

ICPC

Constipation

2.0

10.5

109

549

P25

ICPC

Phase of life problem adult

1.6

10.5

278

1829

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

10.5

336

2302

W12

ICPC

Contraception intrauterine

1.3

10.5

809

6421

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.6

10.5

256

1654

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

10.4

1226

10256

W11

ICPC

Contraception oral

1.3

10.4

917

7405

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

10.4

347

2397

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

10.4

266

1737

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

10.4

207

1273

D05

ICPC

Perianal itching

3.6

10.3

OAA65, ,

SPAT

1.3

10.3

1066

8781

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

10.3

1961

17271

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

2.3

10.3

354

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.8

10.3

186

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

10.2

213

1324

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

10.2

278

1840

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.8

10.2

140

774

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

10.2

406

2901

ZXA05

NOMESCO Finland

Left side

1.3

10.2

644

4966

L04AA01

ATC

[U] ciclosporin

2.9

10.2

159

S00.7

ICD-10 Finland

Multiple superficial injuries of head

4.0

10.2

P76

ICPC

Depressive disorder

1.4

10.2

390

2767

N02BF02

ATC

pregabalin; oral

1.6

10.2

218

1365

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

10.2

203

1249

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.2

10.1

382

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.1

10.1

468

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

10.1

154

879

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.0

10.1

106

536

S20.2

ICD-10 Finland

Contusion of thorax

1.7

10.1

171

1006

R52.2

ICD-10 Finland

Other chronic pain

1.8

10.1

141

784

C05AA01

ATC

hydrocortisone; rectal, topical

1.9

10.1

121

641

L43.8

ICD-10 Finland

Other lichen planus

2.7

10.1

199

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

1.9

10.0

114

593

L20.0

ICD-10 Finland

Besnier prurigo

1.4

10.0

462

3388

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

10.0

1118

9291

TLC02

NOMESCO Finland

Simple extraction of IUD

1.6

10.0

241

1552

N63

ICD-10 Finland

Unspecified lump in breast

1.5

10.0

330

2277

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

10.0

257

1682

S12

ICPC

Insect bite/sting

1.6

9.9

234

1499

K58

ICD-10 Finland

Irritable bowel syndrome

1.8

9.9

140

781

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

9.9

190

1156

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.1

9.9

399

SPAT1336

SPAT

Request for examination

1.9

9.9

130

710

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

9.9

229

1462

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

9.9

187

1135

N30.8

ICD-10 Finland

Other cystitis

3.0

9.9

146

EMB10

NOMESCO Finland

Tonsillectomy

1.4

9.8

397

2846

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

9.8

409

2948

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

9.8

186

1130

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

9.8

452

3317

F50.2

ICD-10 Finland

Bulimia nervosa

2.4

9.8

268

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.1

9.7

435

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

9.7

297

2016

K04.08

ICD-10 Finland

Other specified pulpit

1.4

9.7

415

3004

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

9.7

340

2372

D07AB08

ATC

desonide; topical

1.4

9.7

448

3287

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

9.7

773

6160

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

9.7

324

2242

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.5

9.6

260

1719

N05BE01

ATC

buspirone; oral

1.9

9.6

116

616

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.5

9.6

262

1736

N39.3

ICD-10 Finland

Stress incontinence

1.6

9.6

235

1520

E29.1

ICD-10 Finland

Testicular hypofunction

2.9

9.6

154

W19

ICD-10 Finland

Unspecified fall

1.5

9.5

310

2131

Z3232

NOMESCO Finland

Midwife

1.3

9.5

623

4833

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.5

9.4

218

M77.4

ICD-10 Finland

Metatarsalgia

1.5

9.4

250

1648

K03.80

ICD-10 Finland

Irradiated enamel

1.5

9.3

270

1812

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.4

9.3

249

K03.2

ICD-10 Finland

Erosion of teeth

2.0

9.3

449

R07

ICPC

Sneezing/nasal congestion

1.4

9.3

399

2889

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

9.3

146

842

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

9.3

1569

13619

R60.1

ICD-10 Finland

Generalized oedema

3.3

9.3

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

9.3

200

1255

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

9.3

227

1469

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

2.9

9.3

146

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

9.5

9.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

9.2

957

7876

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

9.2

130

726

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

9.2

574

4416

M01AC06

ATC

meloxicam; systemic, rectal

1.2

9.2

1168

9839

S01

ICPC

Pain/tenderness of skin

1.7

9.2

163

973

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

1.8

9.2

127

706

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

9.1

143

824

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

9.1

334

2350

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

9.1

243

1602

J35.0

ICD-10 Finland

Chronic tonsillitis

1.4

9.1

361

2578

N06BA12

ATC

lisdexamfetamine; oral

2.1

9.1

386

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

9.1

244

1611

N71.9

ICD-10 Finland

Inflammatory disease of uterus, unspecified

2.4

9.1

246

S01AD03

ATC

aciclovir; ophthalmic

1.9

9.1

116

628

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.1

272

1839

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.8

9.1

153

Z25

ICPC

Assault/harmful event problem

2.5

9.1

222

S76

ICPC

Skin infection other

1.7

9.1

165

991

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.7

9.1

172

1045

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

9.1

147

856

A29

ICPC

General symptom/complaint other

1.4

9.0

398

2896

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.1

9.0

414

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.0

1645

14379

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.8

9.0

121

666

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

9.0

398

2898

WYA30, ,

SPAT

3.3

9.0

101

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

9.0

120

659

D02

ICPC

Abdominal pain epigastric

1.5

9.0

266

1795

S10

ICPC

Boil/carbuncle

1.6

9.0

220

1424

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

9.0

170

1033

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.0

9.0

504

N05AX12

ATC

aripiprazole; systemic

1.5

9.0

240

1585

S48

ICPC

Skin, Clarification/discussion RFE/demand

3.8

8.9

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

3.6

8.9

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

8.9

196

1236

TQW02

NOMESCO Finland

Removal of wart

18.6

8.9

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

2.3

8.9

292

N06AG02

ATC

moclobemide; oral

1.8

8.9

126

705

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.7

8.9

162

975

D07AA02

ATC

hydrocortisone; topical

1.3

8.8

663

5237

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

8.8

225

1470

R52.0

ICD-10 Finland

Acute pain

1.7

8.8

152

901

J02.0

ICD-10 Finland

Streptococcal pharyngitis

1.7

8.8

172

1054

WX402

NOMESCO Finland

General anaesthesia

1.3

8.8

831

6762

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3.8

8.8

B02AA02

ATC

tranexamic acid; systemic

1.3

8.8

652

5143

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.7

108

579

O04.1

ICD-10 Finland

Medical abortion, incomplete, complicated by delayed or excessive haemorrhage

2.3

8.7

282

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.7

267

1814

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

2.8

8.7

151

S72

ICPC

Scabies/other acariasis

2.4

8.7

245

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

4.1

8.7

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.3

8.7

788

6379

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

8.6

846

6910

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.6

8.6

177

1098

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.0

8.6

422

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

8.6

148

877

F34.1

ICD-10 Finland

Dysthymia

1.6

8.6

180

1123

M01AH01

ATC

celecoxib; oral

1.4

8.5

479

3627

F50.1

ICD-10 Finland

Atypical anorexia nervosa

2.4

8.5

223

ZA8.2

ICD-10 Finland

Fault, injury or illness on the neck or neck

2.9

8.5

131

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

8.5

193

1227

M01AH02

ATC

rofecoxib; oral

1.5

8.5

277

1906

N06AA12

ATC

doxepin; systemic

1.8

8.5

123

693

X99

ICPC

Genital disease female other

2.8

8.5

148

W60

ICPC

Pregnancy, Result test/procedure

2.8

8.5

148

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

8.5

172

1065

H81

ICPC

Excessive ear wax

1.4

8.5

393

2887

G04CB01

ATC

finasteride; oral

1.8

8.5

114

629

S88

ICPC

Dermatitis contact/allergic

1.9

8.4

487

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

2.5

8.4

212

M75

ICD-10 Finland

Shoulder lesions

1.7

8.4

154

927

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

3.7

8.4

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

8.4

1037

8695

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

8.4

170

1051

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

8.4

1622

14234

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

8.4

313

L04

ICPC

Chest symptom/complaint

1.5

8.4

230

1528

F52.2

ICD-10 Finland

Failure of genital response

2.5

8.4

213

R41.3

ICD-10 Finland

Other amnesia

2.3

8.4

256

Z29

ICPC

Social problem NOS

1.9

8.3

106

574

A51.9

ICD-10 Finland

Early syphilis, unspecified

+∞

8.3

L13.9

ICD-10 Finland

Bullous disorder, unspecified

3.4

8.3

N75.0

ICD-10 Finland

Cyst of Bartholin gland

2.3

8.3

269

K05.22

ICD-10 Finland

Acute pericoronitis

1.4

8.3

391

2878

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

8.3

147

878

K05.08

ICD-10 Finland

Another acute gingivitis

1.7

8.3

154

932

X60

ICPC

Female Genital, Result test/procedure

4.1

8.2

R04.2

ICD-10 Finland

Haemoptysis

2.1

8.2

348

W55

ICD-10 Finland

Bitten or struck by other mammals

1.6

8.2

170

1057

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

8.2

402

ZA1.0

ICD-10 Finland

Shoulder region

2.1

8.2

355

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.4

8.2

227

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

8.2

111

613

R03DC03

ATC

montelukast; oral

1.3

8.2

701

5628

Z72.1

ICD-10 Finland

Alcohol use

2.4

8.2

215

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.5

8.2

197

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

8.2

416

G02.0*B00.3

ICD-10 Finland

Herpesviral meningitis

14.5

8.2

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

8.2

207

1351

SFA00

NOMESCO Finland

Small restoration

1.3

8.2

548

4261

A85

ICPC

Adverse effect medical agent

2.9

8.1

129

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

8.1

327

2342

RS221, ,

NOMESCO Finland

2.4

8.1

228

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

8.1

399

2957

B00.5

ICD-10 Finland

Herpesviral ocular disease

4.4

8.1

W14

ICPC

Contraception female other

1.4

8.1

454

3435

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

8.1

315

2242

N90.4

ICD-10 Finland

Leukoplakia of vulva

4.8

8.1

A10AB04

ATC

insulin lispro; parenteral

1.8

8.1

125

719

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.1

192

1235

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.0

8.0

433

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

8.0

332

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.6

8.0

172

1080

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

1.9

8.0

100

539

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.7

8.0

130

759

D01AC03

ATC

econazole; topical

1.7

8.0

156

957

A60

ICPC

General and Unspecified, Result test/procedure

1.7

8.0

151

919

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.9

8.0

100

540

Z30.8

ICD-10 Finland

Other contraceptive management

1.5

8.0

227

1521

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.1

8.0

353

D07XC01

ATC

betamethasone; topical

1.4

7.9

363

2660

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

7.9

287

2017

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.3

7.9

N83.0

ICD-10 Finland

Follicular cyst of ovary

2.0

7.9

374

SPAT1360

SPAT

Extensive global examination

1.5

7.9

214

1418

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.8

7.9

103

563

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

7.9

284

1994

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

7.9

405

3025

N34.1

ICD-10 Finland

Nonspecific urethritis

4.6

7.9

SPAT1260

SPAT

Consultation of another employee

1.3

7.9

659

5277

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

7.9

380

2810

Y99

ICPC

Genital disease male other

7.7

7.9

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.0

7.9

416

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.8

1350

11703

EBA05, ,

SPAT

2.1

7.8

342

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.9

7.8

536

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.4

7.8

360

2641

R55

ICD-10 Finland

Syncope and collapse

1.4

7.8

283

1990

H16.0

ICD-10 Finland

Corneal ulcer

1.6

7.8

194

1262

L13

ICPC

Hip symptom/complaint

1.3

7.8

483

3713

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.6

7.8

186

1199

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

7.7

439

3329

L57.0

ICD-10 Finland

Actinic keratosis

1.7

7.7

148

903

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.0

7.7

384

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.8

7.7

133

R29

ICPC

Respiratory symptom/complaint other

1.5

7.7

259

1795

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

7.7

242

1655

R03BA01

ATC

beclometasone; inhalant

1.3

7.7

473

3631

F01

ICPC

Eye pain

1.7

7.7

129

760

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

3.1

7.7

G47.3

ICD-10 Finland

Sleep apnoea

1.3

7.7

664

5339

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.4

7.7

216

H60

ICD-10 Finland

Otitis externa

1.5

7.6

229

1551

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.5

7.6

198

1300

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

2.7

7.6

151

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

3.7

7.6

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

7.6

254

1758

A74.9

ICD-10 Finland

Chlamydial infection, unspecified

8.0

7.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

7.6

339

2476

L29

ICD-10 Finland

Pruritus

2.1

7.6

340

R30.9

ICD-10 Finland

Painful micturition, unspecified

2.7

7.6

146

G03CA04

ATC

estriol; systemic, vaginal

2.0

7.6

429

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

7.5

307

S22.3

ICD-10 Finland

Fracture of rib

1.6

7.5

187

1216

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

7.5

189

1232

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.4

7.5

355

2615

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.0

7.5

423

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

7.5

223

1508

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1.9

7.5

445

Y07

ICD-10 Finland

Other maltreatment

2.6

7.4

153

D82

ICPC

Teeth/gum disease

1.2

7.4

1889

16942

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.5

7.4

208

1389

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

7.4

192

1260

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

7.4

392

2941

A56.4

ICD-10 Finland

Chlamydial infection of pharynx

7.6

7.4

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.3

7.4

785

6469

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.7

7.3

134

808

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

7.3

107

606

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

7.3

207

1385

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.4

7.3

190

N41.1

ICD-10 Finland

Chronic prostatitis

2.2

7.3

246

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

7.3

351

2594

S82

ICPC

Naevus/mole

1.3

7.3

557

4406

ZXC10

NOMESCO Finland

Use of laser

2.1

7.3

318

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.6

7.3

143

879

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

7.3

470

R5599

NOMESCO Finland

Other rehabilitation service

1.9

7.3

506

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

7.3

345

2545

TQX20

NOMESCO Finland

Implantation of subcutaneous medicament implant

2.6

7.3

155

N06AX22

ATC

agomelatine; oral

1.7

7.2

122

720

A69.2

ICD-10 Finland

Lyme disease

1.6

7.2

171

1100

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.5

7.2

167

L70.0

ICD-10 Finland

Acne vulgaris

1.5

7.2

222

1512

A51.3

ICD-10 Finland

Secondary syphilis of skin and mucous membranes

15.8

7.2

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.9

7.2

415

A08

ICPC

Swelling

1.7

7.2

124

736

M62.6

ICD-10 Finland

Muscle strain

1.7

7.2

135

820

A23

ICPC

Risk factor NOS

1.3

7.2

428

3269

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.7

7.2

130

782

F50.9

ICD-10 Finland

Eating disorder, unspecified

1.9

7.2

465

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.7

7.2

116

677

H03AA01

ATC

levothyroxine sodium; systemic

1.2

7.2

854

7123

L20

ICD-10 Finland

Atopic dermatitis

1.6

7.2

181

1182

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.9

7.2

416

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

7.2

151

945

D23

ICD-10 Finland

Other benign neoplasms of skin

1.8

7.2

103

581

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

7.1

162

1032

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

7.1

122

723

L29

ICPC

Musculoskeletal sympt/complt other

1.4

7.1

292

2100

N03AF01

ATC

carbamazepine; oral, rectal

1.7

7.1

129

777

A10AA02, ,

ATC

1.8

7.1

102

575

N02BF01

ATC

gabapentin; oral

1.4

7.1

268

1899

F43.00

ICD-10 Finland

Acute stress reaction mild

1.6

7.1

143

885

N93

ICD-10 Finland

Other abnormal uterine and vaginal bleeding

2.7

7.1

128

Y09

ICD-10 Finland

Assault by unspecified means

2.9

7.1

106

S61.8

ICD-10 Finland

Open wound of other parts of wrist and hand

1.8

7.1

539

L30.4

ICD-10 Finland

Erythema intertrigo

2.4

7.1

199

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.1

247

1725

G04BD12

ATC

mirabegron; oral

1.5

7.1

229

1576

K03.1

ICD-10 Finland

Abrasion of teeth

1.9

7.1

411

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

7.1

114

665

B37.0

ICD-10 Finland

Candidal stomatitis

2.5

7.1

175

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.1

7.1

329

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

7.1

412

3139

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.6

7.0

177

1155

SPAT1308

SPAT

Sexual health counselling

1.2

7.0

1117

9593

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.5

7.0

230

1587

P01AB02

ATC

tinidazole; oral, rectal

2.0

7.0

350

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

7.0

371

P15

ICPC

Chronic alcohol abuse

1.8

7.0

104

593

J01FA09

ATC

clarithromycin; systemic

1.2

7.0

1287

11209

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.7

7.0

127

766

T11.1

ICD-10 Finland

Open wound of upper limb, level unspecified

3.5

7.0

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

3.3

7.0

B35.1

ICD-10 Finland

Tinea unguium

1.5

6.9

208

1410

P17

ICPC

Tobacco abuse

2.1

6.9

291

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

6.9

310

2264

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.8

6.9

100

565

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

6.3

6.9

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.6

6.9

136

837

JF2BD

NOMESCO Finland

Extensive colon CT

3.7

6.9

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.7

6.9

126

761

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.1

6.9

312

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

6.9

152

963

SPAT1254

SPAT

Administration of medicine

1.3

6.9

510

4019

Z12

ICPC

Relationship problem with partner

1.7

6.9

118

701

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.1

6.9

319

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

6.9

150

948

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

6.9

307

2243

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

6.9

160

1027

R25.2

ICD-10 Finland

Cramp and spasm

1.9

6.8

452

D22

ICD-10 Finland

Melanocytic naevi

1.4

6.8

274

1965

B23.8

ICD-10 Finland

HIV disease resulting in other specified conditions

8.3

6.8

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

6.8

402

3068

A07EC02

ATC

mesalazine; oral, rectal

1.5

6.8

201

1359

R06.4

ICD-10 Finland

Hyperventilation

2.0

6.8

382

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

1.9

6.8

474

WX320

NOMESCO Finland

Spinalanesthesy

1.2

6.8

772

6405

R08

ICPC

Nose symptom/complaint other

1.6

6.8

154

982

L18

ICPC

Muscle pain

1.6

6.8

155

990

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.8

6.8

120

SPAT1301

SPAT

No procedures

1.2

6.8

1186

10276

A10AB01

ATC

insulin (human); parenteral

1.6

6.8

132

811

D01AE15

ATC

terbinafine; topical

1.5

6.8

178

1174

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.8

6.8

562

B23.0

ICD-10 Finland

Acute HIV infection syndrome

40.1

6.8

X57

ICD-10 Finland

Unspecified privation

1.9

6.7

397

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.3

6.7

456

3549

R06AE09

ATC

levocetirizine; oral

1.3

6.7

674

5512

QBE99, ,

SPAT

2.9

6.7

104

N80.9

ICD-10 Finland

Endometriosis, unspecified

1.6

6.7

138

859

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

6.7

164

1064

J01DC02

ATC

cefuroxime; systemic

1.5

6.7

219

1511

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

6.7

1358

11923

M54.1

ICD-10 Finland

Radiculopathy

1.7

6.7

128

783

F43.25

ICD-10 Finland

Adaptive disorder with mixed mental disorder and behavioral disorder

2.9

6.7

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

6.7

1039

8902

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

6.6

117

700

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.6

6.6

154

988

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

2.8

6.6

116

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

6.6

159

1028

F32.0

ICD-10 Finland

Mild depressive episode

1.6

6.6

144

910

P99

ICPC

Psychological disorders other

1.6

6.6

154

989

O98.5

ICD-10 Finland

Other viral diseases complicating pregnancy, childbirth and the puerperium

5.9

6.6

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.5

6.6

A07EA06

ATC

budesonide; oral, local oral

1.6

6.6

142

895

ZXD35

NOMESCO Finland

Usual procedure

1.8

6.6

523

MBC10

NOMESCO Finland

Repair of obstetric laceration of vagina

0.5

6.6

1090

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.1

6.6

291

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

6.6

206

1411

F10.24

ICD-10 Finland

Alcohol depence active use

2.2

6.6

232

D01AC02

ATC

miconazole; topical

1.5

6.5

195

1321

N48.5

ICD-10 Finland

Ulcer of penis

8.7

6.5

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

6.5

157

1015

B00.11

ICD-10 Finland

Herpes simplex labialis

1.8

6.5

495

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

3.0

6.5

Z71.1

ICD-10 Finland

Person with feared complaint in whom no diagnosis is made

2.2

6.5

239

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

6.5

453

3539

D01AA02

ATC

natamycin; topical

1.9

6.5

388

X91

ICPC

Condylomata acuminata female

2.8

6.5

106

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.5

907

7688

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

2.2

6.5

227

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

6.5

165

1082

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

2.6

6.4

135

ZX120

NOMESCO Finland

Intravenous

1.4

6.4

269

1943

E06.3

ICD-10 Finland

Autoimmune thyroiditis

2.4

6.4

171

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

3.5

6.4

F61.0

ICD-10 Finland

Mixed personality disorders

1.8

6.4

483

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.4

326

2433

F41

ICD-10 Finland

Other anxiety disorders

1.7

6.4

108

639

S27

ICPC

Fear of skin disease other

3.4

6.4

L09

ICPC

Arm symptom/complaint

1.5

6.4

187

1263

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

2.3

6.4

184

Z37.0

ICD-10 Finland

Single live birth

1.3

6.4

647

5301

S80.0

ICD-10 Finland

Contusion of knee

1.4

6.3

310

2299

L86

ICPC

Back syndrome with radiating pain

1.5

6.3

199

1363

L29.0

ICD-10 Finland

Pruritus ani

2.3

6.3

197

R07.2

ICD-10 Finland

Precordial pain

2.1

6.3

255

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

2.5

6.3

154

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.7

6.3

114

687

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.3

1508

13413

K60.3

ICD-10 Finland

Anal fistula

2.0

6.3

316

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.8

6.3

508

EB1HA, ,

SPAT

1.9

6.3

400

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.6

6.3

124

765

N41.0

ICD-10 Finland

Acute prostatitis

2.4

6.3

179

R06AX13

ATC

loratadine; oral

1.2

6.3

723

6004

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

6.3

165

1089

H04AA01

ATC

glucagon; nasal, parenteral

1.7

6.3

111

666

F73

ICPC

Eye infection/inflammation other

1.8

6.3

509

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

6.3

204

1408

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

6.3

294

2167

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

6.2

324

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

1.7

6.2

103

606

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.8

6.2

502

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.6

6.2

126

782

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

2.7

6.2

120

D02AE01

ATC

carbamide; topical

1.4

6.2

228

1609

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

6.2

429

3348

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.7

6.2

115

698

G03DB01

ATC

dydrogesterone; oral

1.3

6.2

601

4895

J01MA14

ATC

moxifloxacin; systemic

1.4

6.2

248

1778

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.6

6.2

127

791

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

2.1

6.2

284

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

6.2

302

2239

F72

ICPC

Blepharitis/stye/chalazion

1.8

6.2

533

D25

ICPC

Abdominal distension

1.8

6.2

467

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

6.2

245

1754

A27

ICPC

Fear of other disease NOS

1.6

6.2

151

981

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

6.2

452

3556

XQ802

NOMESCO Finland

Epicutan test

1.5

6.2

184

1248

E03

ICD-10 Finland

Other hypothyroidism

1.4

6.2

215

1504

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

6.3

6.2

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.0

6.1

285

S02.50

ICD-10 Finland

Fracture of tooth, closed

1.7

6.1

549

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

1.9

6.1

389

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.0

6.1

306

A02BA04

ATC

nizatidine; systemic

1.6

6.1

146

944

O04.4

ICD-10 Finland

Medical abortion, incomplete, without complication

2.6

6.1

133

T89

ICPC

Diabetes insulin dependent

1.6

6.1

150

976

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.2

6.1

207

Z73.0

ICD-10 Finland

Burn-out

1.4

6.1

219

1541

N71.1

ICD-10 Finland

Chronic inflammatory disease of uterus

3.8

6.1

W01

ICPC

Question of pregnancy

1.8

6.1

448

L50

ICD-10 Finland

Urticaria

1.7

6.1

581

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

6.1

233

1659

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.7

6.1

544

A10AB05

ATC

insulin aspart; parenteral

1.4

6.1

220

1551

R80

ICPC

Influenza

2.0

6.0

287

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

2.3

6.0

189

R13

ICD-10 Finland

Dysphagia

1.5

6.0

178

1206

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2352

11285

3.03

317.24

3.0

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2529

12505

3.05

307.65

3.3

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

530

441

13.31

307.65

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1426

6243

2.79

212.41

2.6

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1649

8029

2.56

195.80

2.8

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

143

18.60

179.34

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2646

16584

2.25

169.74

2.7

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1947

11711

2.08

128.19

2.0

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

192

331

5.99

106.54

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

100

12.57

101.87

2.2

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3552

27629

1.96

100.04

5.0

3.8

2122.60

1251.79

e6/l

0.35

307

(3018095) Leukocytes [#/volume] in Urine

2016

13116

1.89

99.10

3.8

3.2

45.79

74.70

e6/l

2.30

1273

8506

(3037467) Urinalysis macro (dipstick) panel - Urine

3612

28821

1.89

86.89

4.8

3.8

—

(36304419) Bacteria [Presence] in Urine

1527

9484

1.87

83.56

2.9

2.6

—

(3030467) Casts [#/volume] in Urine by Automated count

1510

9421

1.86

80.97

3.0

2.7

0.21

0.31

e6/l

1.43

1067

6945

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

179

373

4.94

80.54

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

956

5124

2.07

80.09

2.8

2.5

3.64

3.98

e6/l

0.45

483

2636

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

397

1452

2.88

78.06

1.8

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1612

10363

1.82

77.83

3.1

2.8

29.27

87.78

e6/l

2.38

1150

7723

(3001964) Herpes simplex virus Ag [Presence] in Specimen

104

8.69

70.13

1.2

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1250

7637

1.85

69.97

2.0

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

663

3342

2.13

64.29

2.6

2.3

32.58

51.44

u/l

0.71

582

2877

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

950

5449

1.92

64.09

2.7

2.4

0.78

1.16

e6/l

2.50

474

2953

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1818

12634

1.69

63.65

1.9

1.7

101.08

98.31

pmol/l

1.58

974

6986

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4296

37692

1.93

59.84

10.8

8.6

94.85

94.47

ml/min/173m2

0.59

3451

30530

(3022096) Basophils/100 leukocytes in Blood

2392

18147

1.60

57.08

6.5

5.8

0.70

0.67

2.71

2209

17031

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

212

646

3.38

56.74

2.4

1.5

2841.90

933.33

titre

—

(3001604) Monocytes [#/volume] in Blood

2590

20074

1.60

56.10

6.5

5.8

0.53

0.54

e9/l

0.41

2244

17801

(3006315) Basophils [#/volume] in Blood

2593

20107

1.59

56.02

6.5

5.8

0.04

e9/l

0.36

2246

17802

(3007164) IgA [Mass/volume] in Serum or Plasma

1476

9973

1.68

55.91

1.5

1.4

2.16

2.13

g/l

0.29

861

6510

(3013650) Neutrophils [#/volume] in Blood by Automated count

2887

22973

1.60

55.79

8.9

8.4

3.85

4.01

e9/l

3.45

2486

20325

(3033658) Prothrombin time (PT) actual/Normal

1319

8675

1.70

55.17

3.8

3.4

97.07

96.30

0.60

1275

8431

(3026008) Bacteria identified in Urine by Culture

1604

11109

1.65

55.02

2.7

2.4

—

(3006504) Eosinophils/100 leukocytes in Blood

2457

18873

1.59

54.80

6.5

5.8

2.79

2.75

0.39

2284

17799

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1872

13503

1.61

54.32

2.0

1.7

—

(3013115) Eosinophils [#/volume] in Blood

2662

20860

1.58

54.28

6.8

6.0

0.18

e9/l

0.06

2336

18741

(3019198) Lymphocytes [#/volume] in Blood

2670

20971

1.58

53.64

6.4

5.7

1.98

e9/l

0.04

2376

19037

(3015736) pH of Urine

2240

16907

1.58

53.38

3.3

2.9

6.06

5.95

1.25

256

1781

(3019069) Monocytes/100 leukocytes in Blood

2461

18991

1.58

53.23

6.7

6.0

8.14

8.00

1.67

2298

17952

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1866

13527

1.60

52.58

5.2

5.1

1.22

1.21

mmol/l

1.55

1725

12474

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3352

27881

1.60

51.64

7.4

6.5

70.51

72.19

u/l

1.30

3163

26364

(3002030) Lymphocytes/100 leukocytes in Blood

2547

19908

1.56

51.37

6.5

5.7

30.51

29.67

4.01

2385

18885

(3018010) Neutrophils/100 leukocytes in Blood

2518

19643

1.56

51.13

6.3

5.5

55.33

56.42

5.48

2357

18627

(40768804) Tissue Pathology biopsy report

2124

16055

1.56

48.89

2.1

1.9

—

(40758558) Short blood count panel - Blood

1381

9437

1.64

48.81

7.3

6.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2422

18890

1.54

48.11

6.6

6.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

2628

20903

1.54

47.43

5.0

4.3

0.00

estimate

0.22

514

4449

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4631

42397

2.10

47.02

13.3

10.1

19.74

19.63

mg/l

0.08

3635

32522

(3011397) Hemoglobin [Presence] in Urine by Test strip

1339

9175

1.62

46.39

3.5

3.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4376

39352

1.83

46.35

5.4

4.7

1.68

1.97

mu/l

2.40

4125

37281

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2284

17698

1.53

46.02

5.4

5.3

10.17

10.20

umol/l

0.05

2125

16673

(3009261) Glucose [Presence] in Urine by Test strip

2633

21044

1.52

45.80

3.6

3.2

0.00

estimate

2.03

507

4345

(3024561) Albumin [Mass/volume] in Serum or Plasma

1835

13637

1.54

44.34

4.6

4.4

37.31

36.80

g/l

4.05

1686

12755

(3035350) Ketones [Presence] in Urine by Test strip

2604

20876

1.51

43.85

3.6

3.1

0.00

estimate

1.60

521

4521

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1997

15167

1.52

43.37

5.7

5.6

1.22

1.21

mmol/l

1.33

1756

12925

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1637

11923

1.55

43.02

1.4

1.3

1.51

1.56

u/ml

0.04

413

3502

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3915

34369

1.62

42.78

4.5

4.1

14.20

14.36

pmol/l

4.59

3610

32058

(3026782) Osmolality of Urine

1031

6732

1.67

42.74

2.7

2.5

538.99

539.01

mosm/kgh2o

0.00

857

5752

(3013707) Erythrocyte sedimentation rate by Westergren method

3428

29224

1.54

42.35

4.2

3.6

8.65

9.27

mm/h

2.71

3207

27403

(3019550) Sodium [Moles/volume] in Serum or Plasma

4397

39869

1.79

41.62

12.2

10.0

139.46

139.52

mmol/l

1.10

4289

38728

(3000850) Epithelial cells [#/volume] in Urine

1078

7173

1.64

41.32

2.5

2.3

10.41

8.01

e6/l

0.65

932

6362

(3023103) Potassium [Moles/volume] in Serum or Plasma

4404

39980

1.79

41.12

12.4

10.0

3.89

3.91

mmol/l

4.05

4290

38729

(3007853) Bacteria identified in Skin by Aerobe culture

731

4463

1.75

38.45

1.7

1.6

—

(3018418) pH of Serum or Plasma

1268

8906

1.57

38.32

3.7

3.5

7.40

1.25

199

1790

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

816

5148

1.70

38.08

2.6

2.41

2.42

mmol/l

0.32

688

4503

(3048689) Calprotectin [Mass/mass] in Stool

991

6595

1.63

37.52

2.5

91.54

106.58

ug/g

0.86

764

5207

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4178

37646

1.63

36.94

4.5

3.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

588

3407

1.82

36.86

1.9

1.8

—

(3000494) Fungus identified in Specimen by Culture

695

4231

1.75

36.82

1.5

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1482

10851

1.52

36.75

3.1

2.9

2.35

2.34

mmol/l

0.18

1300

9878

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2764

22904

1.46

36.37

3.1

2.9

71.88

74.59

ug/l

0.46

2597

21735

(3021960) Folate [Moles/volume] in Serum or Plasma

1005

6777

1.60

35.84

1.5

1.4

20.87

20.55

nmol/l

0.34

893

6041

(3002385) Erythrocyte distribution width [Ratio]

4206

38069

1.62

35.25

15.5

12.2

14.06

14.74

1.92

4148

37415

(3021589) Normoblasts [#/volume] in Blood

2274

18244

1.45

35.02

9.0

8.0

0.00

e9/l

0.66

1835

15074

(3028707) Methadone [Presence] in Urine by Screen method

319

1551

2.13

33.25

4.2

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

760

4872

1.66

32.98

1.8

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

271

1246

2.24

32.48

1.3

1.1

—

(3011288) Drugs identified in Urine by Screen method

456

2535

1.88

32.47

4.7

3.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

480

2739

1.83

31.43

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

946

6468

1.57

31.32

1.9

1.7

1.41

1.36

2.20

851

5845

(3014765) Yersinia sp identified in Stool by Organism specific culture

266

1240

2.21

30.82

1.2

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2023

16171

1.42

30.32

2.3

2.2

75.59

72.80

nmol/l

4.44

1867

15128

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1242

9060

1.49

30.28

1.9

1.7

0.73

0.93

mg/l

3.44

860

6550

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

263

1231

2.20

30.17

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1768

13808

1.43

30.12

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

347

1812

1.98

29.74

1.8

1.7

—

(3025130) Human papilloma virus identified in Specimen

229

1027

2.29

29.13

1.8

1.7

—

(40768797) Stomach Pathology biopsy report

720

4694

1.62

28.94

1.2

—

(3042936) Bacteria identified in Isolate by Culture

712

4646

1.62

28.48

1.9

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4678

44034

1.84

28.19

10.1

8.2

25.20

25.54

u/l

0.59

4546

42741

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1200

8830

1.47

27.60

2.1

141.10

193.79

u/l

1.85

1139

8366

(3016879) Cocaine [Presence] in Urine

550

3390

1.70

27.41

3.3

2.2

—

(3023368) Bacteria identified in Blood by Culture

1041

7468

1.50

27.12

4.3

3.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

625

4032

1.63

26.04

2.7

2.6

5.82

6.68

umol/l

0.84

508

3417

(3037522) Nuclear Ab [Titer] in Serum

884

6180

1.52

25.94

1.4

504.20

584.76

titre

0.59

162

1205

(1001926) Buprenorphine [Presence] in Urine by Screen method

473

2847

1.73

25.65

3.6

2.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

488

2971

1.71

25.38

2.5

2.3

17.50

20.97

au/ml

0.71

285

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1511

11757

1.41

25.21

1.7

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1007

7301

1.47

24.59

1.3

8.62

9.12

u/ml

0.10

395

3147

(3044640) Blood type and Crossmatch panel - Blood

1588

12521

1.39

24.31

2.2

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3714

33533

1.41

24.03

4.5

4.1

37.13

37.45

mmol/mol

1.31

3492

31775

(3013826) Glucose [Moles/volume] in Serum or Plasma

2469

20928

1.35

23.72

4.6

4.1

6.22

6.29

mmol/l

1.05

2277

18673

(3044889) 12 lead EKG panel

2779

24015

1.35

23.34

3.0

2.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

452

2765

1.70

23.03

1.3

31.20

39.18

au/ml

0.44

126

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1405

10937

1.39

22.94

2.9

2.7

30.81

31.17

ng/l

0.01

586

5051

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1676

13437

1.37

22.82

3.4

3.0

28.44

29.68

u/l

0.63

1580

12835

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1046

7736

1.44

22.80

1.4

1.3

24.11

22.38

iu/ml

0.20

294

2421

(3027008) Opiates [Presence] in Urine

571

3717

1.60

22.78

3.3

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

568

3693

1.61

22.77

3.3

2.1

—

(3028300) Cannabinoids [Presence] in Urine

572

3727

1.60

22.73

3.4

2.1

—

(3022145) Colonoscopy Study observation

595

3917

1.59

22.63

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

702

4812

1.53

22.30

1.6

1.7

1080.88

1185.83

nmol/l

2.48

518

3750

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

161

3.95

22.00

11.2

6.4

4683.33

291.38

u/ml

0.73

(3027944) Amphetamines [Presence] in Urine

559

3662

1.59

21.67

3.1

2.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1423

11191

1.38

21.58

2.6

2.4

57.92

57.60

u/l

0.04

1305

10405

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1219

9350

1.40

21.47

2.2

2.1

2.58

2.70

mg/l

1.35

1000

8080

(3012095) Magnesium [Moles/volume] in Serum or Plasma

687

4739

1.52

21.12

3.3

0.82

mmol/l

0.05

648

4460

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3361

30173

1.34

20.29

3.3

2.7

32.97

35.60

u/l

2.18

3200

28841

(3004716) Salmonella sp identified in Stool by Organism specific culture

496

3213

1.60

20.10

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

181

859

2.15

20.10

1.4

305.30

307.25

ug/g

0.04

411

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

122

488

2.54

20.07

2.7

2.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

736

5209

1.48

19.90

3.2

3.0

234.85

454.78

ng/l

1.16

401

2870

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4056

37579

1.40

19.46

3.7

3.4

5.61

mmol/l

0.14

3764

35252

(36660697) Celiac disease serology panel - Serum

605

4136

1.53

19.30

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

355

2144

1.71

18.91

1.7

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

343

2056

1.72

18.78

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

392

2439

1.66

18.65

2.3

2.0

11.82

10.11

nmol/l

3.12

340

2219

(3009508) Creatinine [Moles/volume] in Urine

1199

9356

1.37

18.60

4.1

3.3

20.00

8.09

mmol/l

0.50

1055

8284

(3036481) Cortisol [Moles/volume] in Serum or Plasma

578

3954

1.52

18.34

2.1

2.0

380.87

380.41

nmol/l

0.02

526

3663

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1197

9361

1.37

18.26

2.2

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

438

2820

1.61

18.16

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1140

8884

1.37

17.70

1.6

1.34

1.37

mmol/l

0.47

1008

7765

(40768443) Skin Pathology biopsy report

257

1450

1.81

17.34

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

364

2281

1.64

16.83

6.2

7.2

1.25

1.31

mmol/l

0.86

349

2231

(3026493) Urate [Moles/volume] in Serum or Plasma

1080

8427

1.36

16.47

2.4

2.2

2315.78

3179.67

umol/l

0.50

953

7655

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1022

7913

1.37

16.37

1.6

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

200

1069

1.91

16.02

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

139

653

2.16

15.91

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

325

2012

1.66

15.75

1.1

1.02

2.58

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

716

5271

1.42

15.44

2.6

2.3

4775.07

6750.41

u/l

1.05

257

2196

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

128

592

2.19

15.25

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

128

592

2.19

15.25

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

206

3.08

15.22

2.6

3.1

42.31

46.54

0.87

123

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

319

2.63

14.91

1.9

1.6

—

(40761511) CBC panel - Blood by Automated count

4698

45170

1.57

14.77

11.3

9.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

222

1264

1.79

14.57

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

454

3101

1.51

14.41

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

221

1262

1.79

14.36

3.2

3.8

24.30

24.08

mmol/l

0.52

216

1239

(3037121) Protein [Mass/volume] in Urine

199

1105

1.83

14.19

3.4

3.1

0.24

0.35

g/l

0.88

113

474

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.18

14.11

1.1

—

(3025941) Bacteria identified in Stool by Culture

411

2763

1.53

14.05

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

697

5192

1.40

13.95

2.2

15.10

14.56

umol/l

1.12

651

4839

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

242

2.79

13.60

1.9

1.8

2379952.50

2141127.09

iu/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

235

1388

1.73

13.60

1.4

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

631

4665

1.40

13.16

2.2

2.45

2.46

g/l

0.25

583

4310

(3009542) Hematocrit [Volume Fraction] of Blood

4937

48222

2.03

13.15

19.3

15.1

40.28

40.29

0.04

4826

46040

(3021387) Prolactin [Units/volume] in Serum or Plasma

495

3505

1.46

13.10

1.6

313.63

303.70

mu/l

0.26

445

3124

(3000991) Gas panel - Venous blood

327

2128

1.57

12.93

7.7

8.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

578

4222

1.42

12.91

2.3

25.33

24.20

1.16

509

3649

(3041096) Erythrocytes [Presence] in Urine by Automated

1482

12424

1.27

12.88

3.0

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

144

744

1.96

12.82

1.9

1.8

185.63

175.41

pmol/l

0.39

134

707

(3000963) Hemoglobin [Mass/volume] in Blood

4946

48362

2.06

12.80

19.4

15.2

134.97

135.09

g/l

0.31

4912

47891

(3007461) Platelets [#/volume] in Blood

4940

48285

2.02

12.76

19.3

15.1

260.77

263.28

e9/l

2.19

4868

47336

(3048929) Epstein Barr virus Ab [Presence] in Serum

340

2241

1.55

12.71

1.3

1.2

—

(3035941) MCH [Entitic mass]

4942

48331

2.02

12.43

19.2

15.0

30.20

30.00

15.63

4909

47867

(3024731) MCV [Entitic volume]

4942

48337

2.01

12.33

19.3

15.0

90.38

89.83

16.38

4909

47873

(3026361) Erythrocytes [#/volume] in Blood

4942

48340

2.01

12.28

19.3

15.1

4.49

4.52

e12/l

5.50

4865

47339

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

223

1338

1.70

12.21

1.2

—

(3010813) Leukocytes [#/volume] in Blood

4942

48349

2.00

12.13

19.4

15.1

6.70

6.77

e9/l

1.29

4865

47305

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

240

1472

1.66

12.10

1.4

1.3

—

(3013512) EKG study

999

8018

1.31

12.08

3.0

2.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

276

1756

1.60

12.02

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

109

523

2.11

11.92

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

426

2984

1.47

11.91

2.7

2.5

10.59

10.58

g/l

0.01

393

2740

(3018677) aPTT in Platelet poor plasma by Coagulation assay

604

4520

1.38

11.66

2.3

2.1

29.42

29.30

0.27

587

4356

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1896

16497

1.24

11.61

3.7

3.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

205

1224

1.70

11.45

1.9

1.6

45.44

42.38

nmol/l

0.50

195

1202

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

430

3044

1.45

11.37

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

535

3958

1.39

11.05

1.4

1.3

22.99

21.04

iu/l

0.70

446

3392

(3002256) Pathology report gross observation

626

4759

1.36

10.92

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

334

2267

1.51

10.92

1.8

1.26

1.33

g/l

0.53

303

2117

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

345

2360

1.50

10.86

1.6

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

138

745

1.88

10.84

2.1

2.0

2.76

2.90

g/l

0.95

126

696

(3016018) Differential panel - Cerebral spinal fluid

457

2.12

10.75

1.3

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

434

3116

1.43

10.63

1.7

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

136

736

1.87

10.61

1.2

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

142

780

1.84

10.57

2.1

2.0

6.87

7.25

g/l

2.42

130

731

(3003458) Phosphate [Moles/volume] in Serum or Plasma

493

3627

1.40

10.51

6.5

5.3

1.03

1.04

mmol/l

0.63

471

3393

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

365

2.24

10.41

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

622

4758

1.35

10.41

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

141

779

1.83

10.32

2.1

2.0

3.39

3.60

g/l

1.64

129

731

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

141

779

1.83

10.32

2.1

2.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

718

1.86

10.15

2.2

2.0

10.21

10.39

g/l

0.14

120

667

(3022217) INR in Platelet poor plasma by Coagulation assay

1487

12754

1.24

10.05

8.4

8.2

1.10

1.11

inr

0.25

479

4297

(3003740) Influenza virus B Ag [Presence] in Specimen

181

1085

1.69

10.00

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

450

3287

1.41

10.00

1.5

1.3

431.16

199.63

u/ml

0.51

414

3050

(3024354) Oxygen [Partial pressure] in Venous blood

276

1837

1.53

9.91

2.8

3.0

4.58

4.70

kpa

0.53

265

1778

(3002523) Influenza virus A Ag [Presence] in Specimen

181

1088

1.69

9.91

1.1

—

(1002224) Polysomnography panel

296

2000

1.51

9.90

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1085

8999

1.26

9.88

3.8

3.3

1.02

kg/l

0.04

132

1332

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

391

2792

1.43

9.87

2.9

2.6

0.64

0.68

ug/l

0.22

245

1550

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

218

1379

1.61

9.77

2.3

1.9

0.21

0.23

g/l

2.39

203

1311

(3003338) MCHC [Mass/volume]

4089

38895

1.27

9.73

16.0

12.5

333.31

332.98

g/l

1.66

4067

38594

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

385

2751

1.43

9.69

2.5

2.3

0.23

g/l

1.25

357

2580

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

223

1425

1.59

9.59

2.3

1.9

1.13

1.17

g/l

1.32

210

1357

(3052851) Hemolysis interference index of Serum or Plasma

164

972

1.71

9.47

2.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

115

613

1.90

9.44

1.8

2.0

38.64

38.87

g/l

0.18

103

565

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

124

678

1.85

9.41

2.1

2.2

0.72

0.67

g/l

0.04

111

614

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

709

5614

1.31

9.28

2.4

2.7

517.66

776.43

ng/l

1.41

540

4527

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

115

619

1.88

9.18

1.9

2.0

0.01

g/l

0.06

106

581

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

199

2.58

9.04

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

136

779

1.77

8.88

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

323

2281

1.44

8.67

3.4

3.6

5.83

5.86

kpa

0.20

312

2212

(4062490) Immunoglobulin typing, IgG

421

2.04

8.65

1.4

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

228

1501

1.54

8.64

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

131

749

1.77

8.62

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

272

2.30

8.56

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

372

2.09

8.39

1.0

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2233

20184

1.19

8.31

2.6

2.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

105

568

1.87

8.29

1.9

2.1

0.00

g/l

-0.00

531

(3029937) Albumin [Presence] in Urine by Test strip

1303

11214

1.22

8.21

4.0

3.4

0.01

0.00

estimate

0.51

513

4359

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

104

564

1.86

8.16

1.9

2.1

0.00

g/l

-0.00

529

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

175

1099

1.61

8.14

1.3

414.22

451.80

mg/l

0.92

170

1038

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4141

39642

1.25

8.12

4.0

3.6

2.82

2.86

mmol/l

1.88

3897

37651

(3020630) Protein [Mass/volume] in Serum or Plasma

265

1827

1.48

8.08

2.4

2.3

66.10

67.53

g/l

2.25

245

1702

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

165

2.62

7.92

1.3

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

422

1.98

7.90

1.4

1.5

0.38

g/l

0.03

292

(4200892) Spirometry reversibility

321

2305

1.42

7.89

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

427

3217

1.36

7.86

3.1

3.4

4.47

4.59

pmol/l

1.93

374

2897

(3027135) IgG subclass 1 [Mass/volume] in Serum

423

1.98

7.85

1.4

1.5

6.36

6.53

g/l

0.16

296

(3028192) IgG subclass 2 [Mass/volume] in Serum

423

1.98

7.85

1.4

1.5

3.06

3.00

g/l

0.13

294

(3002032) Base excess in Venous blood by calculation

315

2260

1.42

7.78

3.4

3.6

1.53

1.73

mmol/l

0.51

277

1871

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

421

3178

1.35

7.66

4.8

4.0

226.27

232.79

u/l

0.51

390

3020

(3045414) Leukocytes [Presence] in Urine

254

1762

1.46

7.52

1.9

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

141

857

1.66

7.50

1.1

5.00

10.87

au/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

234

1599

1.49

7.48

2.3

2.1

39.68

38.81

u/l

0.29

209

1494

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

154

960

1.62

7.42

1.2

3.46

3.56

mmol/l

0.88

147

897

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

214

2.35

7.35

2.5

3.4

192.16

166.57

umol/l

0.20

113

(3027945) Reticulocytes/100 erythrocytes in Blood

374

2791

1.37

7.33

2.8

2.7

1.68

1.71

0.30

326

2493

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

387

1.98

7.23

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

350

2.01

7.02

1.9

2.0

19.60

25.49

mg/l

0.68

(44816559) Phosphatidylethanol [Mass/volume] in Blood

163

1046

1.58

6.98

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

266

1890

1.43

6.96

1.3

0.91

1.17

u/ml

0.13

150

(3049717) Cytology report of Urine Cyto stain

113

665

1.72

6.81

1.8

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

467

1.86

6.79

1.5

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4097

39352

1.22

6.78

3.6

3.4

4.72

4.74

mmol/l

0.93

3872

37570

(3042517) Benzodiazepines panel - Urine

2.94

6.68

4.8

2.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

350

1.98

6.67

1.4

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

150

958

1.58

6.58

1.4

1.3

32.96

22.10

e6/l

0.42

115

740

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

150

959

1.58

6.55

1.4

2371.76

4994.15

e6/l

0.27

123

773

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

347

1.97

6.48

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

347

1.97

6.48

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

347

1.97

6.48

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

737

1.66

6.44

6.0

5.2

702.72

934.90

iu/ml

0.18

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.40

6.41

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

215

2.24

6.41

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1.96

6.38

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1.96

6.38

1.1

—

(3017732) Neutrophils [#/volume] in Blood

382

2925

1.33

6.34

2.0

2.3

4.11

4.80

e9/l

1.71

310

2542

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1.96

6.33

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.96

6.16

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

112

677

1.67

6.15

1.4

1.7

0.66

0.69

g/l

0.13

521

(3020961) Endomysium IgA Ab [Titer] in Serum

357

2721

1.34

6.12

1.1

78.33

274.39

titre

—

(3000492) Spirometry study

543

4378

1.27

6.11

1.4

1.3

—

(3019225) pH of Specimen

372

2858

1.33

6.04

3.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

139

891

1.58

6.04

1.5

1.3

2.32

3.53

u/ml

0.30

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4067

39144

1.20

6.02

3.6

3.3

1.50

1.48

mmol/l

1.36

3833

37288

(3024928) Oxygen saturation in Venous blood

546

1.74

5.98

2.1

2.7

—

(3036180) Methadone [Presence] in Urine

365

1.90

5.95

3.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

205

1432

1.45

5.93

2.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.01

5.89

1.5

1.6

0.90

1.83

mg/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

579

1.71

5.88

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

186

1278

1.47

5.86

1.5

1.3

7.83

44.23

u/ml

4.08

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

171

1163

1.49

5.68

1.5

1.3

6.37

10.90

u/ml

0.74

187

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

185

1279

1.46

5.66

2.2

2.4

164.72

168.07

0.24

175

1201

(3047007) Chlamydophila sp Ab [Presence] in Serum

121

764

1.60

5.63

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

121

2.57

5.61

1.3

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

176

2.28

5.61

1.2

1.3

111.64

107.63

0.57

155

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

258

1903

1.37

5.50

3.7

3.5

70.04

75.50

ng/l

0.85

225

1707

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

243

2.07

5.50

1.6

1.4

148.61

152.32

pmol/l

0.07

243

(3020779) Urea [Moles/volume] in Serum or Plasma

291

2191

1.35

5.44

7.2

7.03

7.48

mmol/l

0.73

277

2111

(3012501) Base excess in Blood by calculation

108

669

1.63

5.44

2.6

3.1

1.84

2.18

mmol/l

0.78

399

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

124

795

1.57

5.42

1.3

1.2

5.32

3.64

u/ml

0.57

337

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.82

5.40

1.4

1.3

0.24

0.42

nmol/l

1.04

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

192

2.20

5.39

1.3

0.28

g/l

0.23

153

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

541

4425

1.25

5.39

1.3

1.2

148.83

150.93

iu/ml

0.04

183

1740

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

585

4827

1.24

5.38

4.2

3.8

1.67

1.87

ug/l

0.70

529

4393

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

167

1145

1.47

5.35

1.5

1.3

13.49

6.19

u/ml

0.46

116

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

177

1237

1.45

5.15

10.0

10.5

24.03

24.20

mmol/l

0.37

166

1216

(3000060) B lymphocytes [#/volume] in Blood

145

2.35

5.14

1.9

2.5

185.00

172.86

e6/l

0.09

(3044290) Cell count panel - Cerebral spinal fluid

136

903

1.52

5.11

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

300

2294

1.33

5.08

1.5

1.3

9.08

9.14

u/l

0.03

243

1914

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

161

1109

1.47

5.06

1.8

1.6

117.14

281.74

titre

—

(3023410) Appearance of Cerebral spinal fluid

454

1.73

5.00

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

148

1007

1.48

4.96

2.2

10.77

10.32

mg/l

0.36

137

953

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

456

3697

1.26

4.91

3.6

3.3

33.13

32.29

0.81

328

2819

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

142

2.33

4.90

1.2

1.1

—

(3008898) HLA-B27 [Presence]

300

2306

1.32

4.90

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

549

1.65

4.86

2.9

2.7

93.40

1436.68

u/ml

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

405

3243

1.27

4.85

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

133

890

1.51

4.84

1.5

1.6

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

1.82

1.80

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

0.53

5.38

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

2.68

2.45

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

0.82

1.39

mg/l

0.44

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

3.94

0.90

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

1.68

2.01

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

0.49

1.76

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.22

4.81

1.5

1.6

1.07

0.45

mg/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

299

1.88

4.77

2.1

2.4

—

(3014051) Protein [Presence] in Urine by Test strip

144

988

1.47

4.65

2.6

2.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

309

1.85

4.65

2.3

2.8

500.14

543.51

e6/l

0.37

260

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

302

1.86

4.64

2.3

2.9

0.18

0.21

e9/l

0.79

259

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

513

1.65

4.54

1.1

—

(3011412) CD3 cells [#/volume] in Blood

400

1.74

4.52

2.3

2.8

1.17

1.33

e9/l

1.10

356

(40767503) Oxygen content in Capillary blood by calculation

593

1.60

4.47

2.0

2.2

17.53

16.84

1.07

286

(44813793) Dust mix specific IgE antibody measurement

394

1.74

4.47

1.1

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

156

1097

1.44

4.45

1.3

1.2

252.55

248.87

u/ml

0.06

115

704

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

163

1157

1.42

4.42

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

124

2.35

4.40

1.1

—

(3051651) Icteric interference index of Serum or Plasma

196

2.05

4.37

3.5

3.4

—

(3051611) Lipemic interference index of Serum or Plasma

287

1.86

4.36

3.5

2.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

144

1002

1.45

4.35

1.4

1.3

101.19

104.50

u/ml

0.14

218

(3010421) pH of Blood

119

799

1.50

4.30

3.0

7.42

0.14

111

716

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

149

1046

1.44

4.30

1.4

1.3

43.04

41.99

u/ml

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

592

1.58

4.28

6.0

5.7

368.59

371.90

umol/l

0.07

509

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

553

1.60

4.27

2.4

2.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

145

2.21

4.26

1.3

1.2

3.83

3.80

iu/ml

—

(3003694) ABO and Rh group [Type] in Blood

1726

15856

1.13

4.26

1.7

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

273

3489

0.77

4.24

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

461

3806

1.23

4.24

3.6

3.4

22.09

20.98

0.61

160

1454

(3035637) Corticotropin [Mass/volume] in Plasma

485

1.64

4.21

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

159

2.15

4.20

1.1

1.2

69.69

83.39

u/l

0.50

140

(3000475) Leukocytes [#/volume] in Synovial fluid

611

1.57

4.19

1.8

1.7

9946.03

9903.55

e6/l

0.01

457

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

774

6719

1.18

4.18

1.5

17829885.11

33402378.86

pmol/l

0.55

645

5829

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

162

1162

1.41

4.16

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3888

37584

1.15

4.15

3.3

3.1

1.20

1.22

mmol/l

1.06

3638

35704

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

511

4275

1.22

4.14

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

169

1224

1.39

4.11

1.5

1.4

19.82

18.65

u/l

0.21

144

1026

(3007566) Smooth muscle Ab [Titer] in Serum

152

1084

1.41

4.05

1.2

1.3

63.75

130.29

titre

1.60

104

(3030981) Hyaline casts [#/volume] in Urine by Automated count

210

1581

1.34

4.02

2.8

2.4

0.12

0.24

e6/l

2.77

201

1513

(3036071) Salmonella sp Ab [Titer] in Serum

176

2.05

3.99

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

156

2.12

3.99

1.1

1.2

11.81

23.55

u/l

1.31

137

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

130

2.24

3.98

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

185

1368

1.37

3.98

2.1

92.67

94.29

0.45

176

1302

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

143

2.18

3.98

1.4

1.3

—

1282.00

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

320

2555

1.27

3.97

1.5

1.4

—

(3012516) Albumin [Mass/volume] in Urine

821

7195

1.17

3.94

3.9

3.4

742.13

349.61

mg/l

1.05

554

4757

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

127

883

1.45

3.89

1.1

2.17

3.00

u/ml

0.59

484

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

149

1067

1.41

3.89

1.4

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.79

3.88

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

435

3611

1.22

3.82

4.8

—

(40761536) Microorganisms panel - Urine sediment

479

4015

1.21

3.82

3.8

3.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

315

1.75

3.81

1.1

8.77

7.75

iu/ml

0.12

(3005033) Fetal Nuchal fold Thickness US

386

3165

1.24

3.81

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

473

3963

1.21

3.79

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

252

1965

1.30

3.78

1.6

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

471

3948

1.21

3.75

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

121

840

1.45

3.75

1.3

1.2

6.29

3.07

u/ml

0.67

285

(3047352) Trisomy 18 risk [Likelihood] in Fetus

386

3172

1.23

3.73

1.4

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

101

677

1.50

3.73

1.6

1.4

—

(1616796) Gas panel - Central venous blood

645

1.51

3.72

2.4

2.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

473

3970

1.21

3.72

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

473

3972

1.21

3.70

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

410

1.64

3.67

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

360

2944

1.24

3.65

1.4

1.3

230.26

232.68

miu/ml

0.04

164

1510

(4035726) Immunohistochemistry procedure

314

2533

1.26

3.60

1.4

—

(3036489) Thrombin time

205

1566

1.32

3.59

2.0

21.01

20.83

0.15

182

1302

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

150

2.07

3.56

1.3

1.4

10.56

19.14

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

285

1.76

3.55

2.7

2.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.05

3.52

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

847

7505

1.15

3.50

4.6

4.0

11.34

11.13

mg/mmol

0.04

575

4996

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

286

2290

1.26

3.50

1.6

1.7

3.81

4.28

mg/l

0.31

207

1594

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

157

1160

1.36

3.44

2.2

2.1

1.28

1.35

g/l

0.49

136

1013

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

314

2552

1.25

3.39

2.5

2.3

80.59

78.83

ml/min/173m2

0.30

120

958

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

189

1442

1.32

3.36

2.6

2.0

—

(3013762) Body weight Measured

5.72

3.34

1.0

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

218

1.84

3.30

1.3

1.6

1.92

3.38

nmol/l

0.67

173

(3007463) Buprenorphine [Presence] in Urine

2.92

3.29

11.4

4.7

—

(3022621) pH of Urine by Test strip

308

2512

1.24

3.23

2.7

2.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

237

2973

0.79

3.23

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

103

2.24

3.21

4.4

2.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

191

1470

1.31

3.21

1.4

1.5

0.44

0.49

nmol/l

0.33

157

1216

(3009343) pH of Capillary blood

206

1603

1.30

3.19

2.7

2.8

7.42

7.41

0.39

230

(3029075) Extractable nuclear Ab panel - Serum

123

2.12

3.19

1.1

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

653

1.46

3.16

2.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

208

1623

1.29

3.16

2.7

2.8

5.14

5.10

kpa

0.37

198

1560

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

320

1.66

3.11

2.6

2.9

40421.83

40548.39

ug/l

0.02

320

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

223

1.80

3.10

4.0

4.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

470

1.54

3.07

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.33

3.07

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.44

3.04

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

577

1.48

3.03

2.0

2.1

7.07

5.17

mmol/24h

1.04

532

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

111

793

1.41

3.02

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

643

1.45

3.02

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

203

1590

1.29

3.01

2.2

2.3

3.89

5.22

umol/l

1.55

132

1165

(3025018) Bordetella pertussis Ab [Titer] in Serum

294

1.67

2.96

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

121

881

1.38

2.96

2.1

2.3

303.32

341.45

ug/l

0.11

106

795

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

176

1.88

2.94

1.7

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

198

1552

1.29

2.93

2.8

0.71

1.32

mmol/l

1.58

146

1086

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

170

1306

1.31

2.92

2.5

3.51

3.59

g/l

0.32

157

1221

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.71

2.91

1.3

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

240

1929

1.26

2.90

2.5

2.6

70.71

72.15

e9/l

0.24

160

1405

(3004616) Nuclear Ab [Presence] in Serum

485

1.51

2.90

1.5

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

112

808

1.39

2.90

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

123

902

1.37

2.88

4.0

3.2

1.34

1.30

mg/l

0.32

114

849

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

2.86

3.3

3.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

447

1.53

2.84

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

183

1427

1.29

2.83

2.3

2.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

448

1.52

2.81

1.5

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

424

1.54

2.81

12.5

11.2

0.58

0.61

mmol/l

0.46

382

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.77

2.81

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.45

2.79

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

339

2840

1.21

2.78

4.4

0.01

0.48

1.32

629

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.08

2.76

1.2

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

105

2.10

2.68

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

446

1.51

2.66

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

133

1.96

2.64

1.0

1.2

2.00

13.11

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

447

1.51

2.64

1.5

—

(40761535) Cells panel - Urine sediment

308

2571

1.21

2.64

3.9

3.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

496

1.48

2.63

1.2

27.12

38.06

mg/l

5.00

407

(3019897) Erythrocyte distribution width [Ratio] by Automated count

984

0.68

2.62

3.3

2.1

13.11

13.05

0.26

974

(3005988) Vibrio sp identified in Specimen by Organism specific culture

448

1.50

2.61

1.5

—

(3011985) Renin [Units/volume] in Plasma

448

1.50

2.61

1.6

1.7

28.34

56.44

mu/l

3.20

403

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

251

1.68

2.61

1.2

1.5

5.38

5.86

u/l

0.35

210

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

186

1471

1.27

2.60

1.8

1.6

0.01

0.37

iu/ml

1.98

269

(3023430) Cat dander IgE Ab [Units/volume] in Serum

132

997

1.33

2.60

1.1

4.47

5.80

u/ml

0.39

433

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

457

1.49

2.59

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

298

1.62

2.58

1.1

1.2

56.55

59.50

u/l

0.14

278

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

417

1.52

2.58

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

120

895

1.35

2.57

1.2

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

146

1123

1.31

2.54

2.4

2.8

1.49

1.36

0.61

146

1117

(3008536) Aspergillus sp Ab [Presence] in Serum

2.50

2.52

3.7

2.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

453

1.49

2.49

1.5

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

224

1822

1.24

2.48

2.1

2.2

6.06

6.30

ug/l

0.06

177

1618

(3021440) Promyelocytes/100 leukocytes in Blood

349

2966

1.19

2.48

4.4

0.07

0.14

1.00

754

(3040151) Glucose [Moles/volume] in Capillary blood

341

1.56

2.48

5.3

4.9

6.39

6.71

mmol/l

0.27

272

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

151

1.86

2.46

1.3

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

479

1.47

2.46

1.1

204.44

217.98

mg/l

0.50

413

(3014133) Dog dander IgE Ab [Units/volume] in Serum

141

1085

1.31

2.45

1.1

3.36

4.70

u/ml

0.35

540

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

439

1.49

2.44

1.6

2.0

19.64

21.13

nmol/l

0.58

421

(40768793) Breast Pathology biopsy report

124

938

1.33

2.44

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

297

2496

1.20

2.40

2.0

2.5

19.39

36.41

u/ml

7.46

289

2422

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

2.02

2.35

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

1.99

2.35

1.0

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

360

3090

1.18

2.30

4.3

1.09

0.96

0.33

878

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

148

1.83

2.28

2.3

2.1

16.06

15.44

umol/l

0.11

148

(3010726) Horse dander IgE Ab [Units/volume] in Serum

158

1248

1.27

2.28

1.1

1.34

1.94

u/ml

0.64

631

(3008401) Mugwort IgE Ab [Units/volume] in Serum

156

1232

1.27

2.25

1.1

0.79

1.22

u/ml

0.81

546

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

416

1.47

2.21

1.3

1.5

381.27

636.36

pmol/l

0.53

373

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

312

1.54

2.18

1.0

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.50

2.18

1.0

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

318

3710

0.85

2.18

1.5

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

163

1301

1.26

2.17

1.1

5.80

6.36

u/ml

0.17

727

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

242

1.62

2.15

1.2

1.1

2.63

10.42

u/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

140

1098

1.28

2.15

2.2

2.8

0.58

0.66

2.50

140

1092

(3050794) Legionella sp Ab [Presence] in Serum

3.00

2.14

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

114

871

1.32

2.13

1.0

1.1

0.17

0.29

u/ml

0.36

230

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

180

1458

1.24

2.12

1.1

2.34

2.48

u/ml

0.08

736

(3021788) Differential panel - Synovial fluid

487

1.42

2.11

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

101

760

1.34

2.10

1.1

119.17

116.60

0.38

687

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.14

2.08

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

598

5366

1.13

2.08

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.00

2.07

1.2

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

398

1.46

2.06

1.8

1.6

—

(4212803) Bone marrow aspirate examination

3.50

2.05

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

720

1.34

2.05

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

549

1.39

2.05

1.2

1.1

—

1.66

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

184

1.69

2.04

1.7

1.6

7.86

6.36

u/l

0.19

157

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

246

1.59

2.03

1.1

2.66

4.83

nmol/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.40

2.02

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.50

2.01

1.4

1.1

—

(3044941) Cell count panel - Synovial fluid

434

1.43

2.00

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

502

1.40

1.98

1.0

1.1

1.48

g/l

0.02

454

(3022689) Creatine [Moles/volume] in Urine

2.08

1.96

1.8

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

329

1.49

1.95

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

234

1.59

1.92

1.1

18.26

14.56

u/ml

0.25

150

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

235

1.58

1.89

1.1

1.3

97.29

70.04

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

678

1.33

1.89

1.9

2.1

135.56

131.72

g/l

0.99

516

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

195

1616

1.21

1.88

2.4

2.6

102.09

118.00

ng/l

0.51

173

1412

(3037756) Immunofixation for Serum or Plasma

373

1.45

1.88

2.0

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

332

1.48

1.88

1.1

1.00

1.02

u/l

0.16

133

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

941

0.73

1.86

1.4

1.5

6.58

6.72

mmol/l

0.19

857

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

1.90

1.85

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

342

1.47

1.84

1.8

1.7

—

(3045142) Bone marrow Pathology biopsy report

277

1.52

1.83

1.3

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

419

3719

1.14

1.76

1.5

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.98

1.74

1.6

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

363

1.44

1.74

1.9

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

364

1.43

1.72

1.1

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.85

1.71

1.6

2.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

316

2757

1.16

1.71

8.6

7.7

5.01

5.03

kpa

0.13

296

2648

(3027801) Oxygen [Partial pressure] in Arterial blood

316

2757

1.16

1.71

8.6

7.7

13.46

13.44

kpa

0.02

296

2650

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

365

1.43

1.70

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

544

1.35

1.68

4.2

3.2

42.67

35.44

mg/l

0.32

437

(4146454) Self-monitoring of blood glucose

219

1.56

1.67

2.7

2.8

—

(3000330) Specific gravity of Urine by Test strip

185

1547

1.20

1.66

3.4

2.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

192

1612

1.20

1.66

1.1

3.53

4.51

u/ml

0.32

256

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

694

1.30

1.65

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

362

3199

1.14

1.64

2.9

2.6

—

(3003396) Base excess in Arterial blood by calculation

316

2769

1.15

1.62

8.6

7.7

0.31

0.81

mmol/l

1.83

253

2116

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

1.80

1.58

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

106

1.80

1.58

1.2

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.00

1.58

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

347

1.42

1.55

1.4

1.2

0.50

1.49

u/ml

1.87

155

(3027231) Wheat IgE Ab [Units/volume] in Serum

137

1.68

1.55

1.0

0.90

1.04

u/ml

0.08

116

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.89

1.54

1.3

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

544

1.33

1.54

4.2

3.2

24.98

58.04

mg/l

1.69

434

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

122

1.72

1.54

1.1

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

145

1.66

1.53

1.0

1.2

—

0.06

g/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

399

1.38

1.52

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

2.59

1.51

1.1

—

(3024263) Appearance of Synovial fluid

138

1.67

1.51

1.4

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

193

1.56

1.50

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.43

1.47

1.1

—

(3021901) Oxygen saturation in Capillary blood

453

1.35

1.47

2.0

2.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.12

1.44

7.5

6.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

533

1.32

1.44

4.0

3.2

1.00

1.54

ratio

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

328

1.41

1.42

1.9

1.7

49.90

50.02

0.01

206

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.25

1.40

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.61

1.36

1.8

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

222

0.54

1.34

2.0

3.1

0.87

0.86

nmol/l

—

174

(3002179) Metamyelocytes/100 leukocytes in Blood

322

2868

1.13

1.34

4.2

4.1

0.79

0.64

0.43

777

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.87

1.34

3.4

4.3

—

(3011648) Oxygen content in Venous blood

216

1.48

1.32

1.5

2.1

11.11

0.00

216

(3045788) Cell count panel - Pleural fluid

136

1.62

1.32

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

233

1.46

1.31

2.8

2.9

76.47

80.56

mg/l

0.02

167

(3002619) Bacteria identified in Specimen by Culture

1.81

1.31

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

225

1.47

1.30

1.7

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

250

1.44

1.30

1.6

35.20

40.75

0.39

154

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.35

1.29

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

146

1.58

1.25

2.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

113

932

1.22

1.24

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.40

1.24

1.7

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

254

1.42

1.21

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

196

1.48

1.21

1.2

1.4

138.10

130.34

nmol/l

0.33

196

(3022313) Gas panel - Capillary blood

133

1118

1.19

1.21

3.0

2.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

132

1.59

1.20

1.4

1.7

14.29

12.60

u/l

0.55

126

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

205

1.47

1.19

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.83

1.19

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

481

1.29

1.16

1.7

—

(3044927) Protein electrophoresis panel - Urine

190

1.48

1.16

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

368

1.33

1.15

1.3

1.5

1.76

1.32

promille

1.28

286

(40758292) HTLV I+II Ab panel - Serum

1.81

1.15

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

421

1.31

1.14

1.5

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

1.55

1.14

1.1

—

(40768800) Prostate Pathology biopsy report

233

1.42

1.12

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

336

1.34

1.11

3.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

415

3797

1.10

1.11

1.3

—

(3008607) Semen analysis panel

2.26

1.10

1.1

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

285

1.37

1.10

1.2

1.51

1.57

g/l

0.76

285

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

137

0.51

1.09

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

104

1.64

1.09

2.0

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

114

957

1.20

1.08

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

128

1.56

1.08

2.8

3.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.19

1.08

1.9

2.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

153

1.51

1.06

1.3

1.5

6810.93

67075.21

e6/l

1.15

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

445

1.28

1.04

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.96

1.03

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.84

1.02

8.5

7.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

255

1.38

1.02

2.2

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

298

1.35

1.02

1.9

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

196

1.43

1.02

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

307

1.34

1.01

1.5

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

273

1.36

1.00

1.5

1.50

1.49

nmol/l

0.03

247

(3012441) Differential panel - Pleural fluid

147

1.50

1.00

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

239

1.38

1.00

1.6

1.4

18669.37

64355.29

e6/l

0.88

167

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.18

0.98

1.0

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.18

0.98

1.4

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

0.15

—

(3020876) Protein [Mass/time] in 24 hour Urine

275

1.35

0.97

2.9

2.7

2.60

1.81

g/24h

0.59

166

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

100

1.60

0.96

2.5

2.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.85

0.96

1.0

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

199

1.41

0.95

1.1

1.3

177.46

307.35

u/l

1.35

180

(3032057) Clostridioides difficile [Presence] in Stool

1.77

0.94

2.1

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.77

0.94

1.7

1.9

—

(3044009) aPTT.lupus sensitive (LA screen)

1.77

0.94

1.0

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.65

0.94

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

1621

16764

0.95

0.93

2.1

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

409

1.27

0.93

3.0

3.9

1088.33

1028.21

u/ml

0.02

382

(3019174) dRVVT (LA screen)

1.73

0.92

1.0

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

151

1319

1.15

0.92

11.3

10.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.82

0.92

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

331

1.30

0.90

1.3

1.6

294.93

283.73

mosm/kgh2o

1.57

263

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

358

1.29

0.89

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.69

0.88

1.6

1.4

34.43

39.28

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

315

1.30

0.88

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.86

0.87

1.1

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

217

0.64

0.87

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

208

1864

1.12

0.87

1.3

3.63

3.77

ug/l

0.11

193

1762

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.00

0.87

4.2

7.8

5.43

6.31

mmol/l

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

134

1535

0.87

7.6

6.9

24.53

24.17

mmol/l

0.71

126

1457

(3043409) Potassium [Moles/volume] in Arterial blood

748

0.81

0.86

3.2

4.3

3.81

3.80

mmol/l

0.04

742

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

833

1.18

0.86

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

614

1.21

0.84

2.4

2.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

172

1528

1.13

0.83

10.5

9.9

0.73

0.70

0.15

172

1519

(3035933) Granulocytes/100 leukocytes in Blood

171

1.41

0.82

1.1

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.65

0.81

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

294

1.29

0.79

1.1

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

385

0.75

0.79

1.1

1.03

1.04

ratio

—

152

(3017509) Phencyclidine [Presence] in Urine

1.56

0.78

1.0

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

1.59

0.78

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

222

0.67

0.77

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

124

1086

1.15

0.76

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

594

1.20

0.76

2.3

2.5

89.71

104.42

ug/min

0.11

384

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.77

0.76

3.8

2.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.08

0.74

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.08

0.74

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

236

1.32

0.74

1.3

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.84

0.73

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

2.4

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.80

0.72

1.0

1.2

3.09

3.45

mmol/l

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

290

1.28

0.72

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

774

0.84

0.72

1.1

125.91

12396.96

iu/ml

0.63

217

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.58

0.71

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

241

0.70

0.71

2.7

2.3

—

(3022475) Manganese [Moles/volume] in Blood

1.92

0.70

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.92

0.70

1.0

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

177

1.36

0.70

1.8

—

(3018572) Chloride [Moles/volume] in Blood

565

0.81

0.70

13.5

6.8

106.05

105.85

mmol/l

0.14

508

(3020911) Cortisol [Moles/time] in 24 hour Urine

186

1.35

0.69

1.3

1.4

88.41

91.64

nmol/24h

0.06

186

(3032868) Hemoglobin electrophoresis panel in Blood

1.55

0.69

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

436

1.22

0.69

2.2

3.0

1.53

1.38

0.11

403

(3039000) Anion gap in Blood

564

0.81

0.69

13.5

6.8

11.34

11.42

mmol/l

0.06

507

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

482

1.21

0.69

1.3

1.8

—

(3003181) Sodium [Moles/volume] in Urine

364

1.24

0.69

1.4

62.15

65.17

mmol/l

0.20

310

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

187

1.34

0.68

1.6

1.3

5.65

6.20

nmol/l

0.31

178

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

709

6767

1.06

0.67

2.1

2.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

733

1.16

0.67

1.2

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

119

1.43

0.66

2.6

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

119

1.43

0.66

2.6

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

249

0.72

0.66

1.3

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.79

0.66

2.8

1.4

12.16

17.83

nmol/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

162

1.36

0.66

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

171

1.35

0.65

1.4

1624.00

2230.72

e6/l

0.48

115

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

810

1.15

0.65

2.5

2.7

—

(21494434) Karyotype in Bone marrow

206

1.31

0.65

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.57

0.65

1.1

1.3

—

(21494755) Public health laboratory ask at order entry panel

637

6673

0.95

0.62

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

138

1.38

0.62

1.7

1.5

5.33

4.84

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

772

0.85

0.62

3.2

3.1

26.21

23.22

mg/l

0.23

465

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

102

0.59

0.62

1.0

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.63

0.62

1.3

1.6

62.75

96.67

ng/l

—

(3017704) Immunofixation for Urine

1.46

0.61

1.1

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

489

1.19

0.61

3.3

4.4

128.72

65.10

u/ml

0.50

156

(3024471) HLA-A [Type]

113

1.42

0.61

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

308

1.24

0.59

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

263

1.26

0.59

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

705

1.15

0.59

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

697

1.15

0.58

1.7

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

106

1.42

0.57

1.4

1.5

—

(3006462) Nitrate [Presence] in Urine

193

1.30

0.57

2.2

2.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

202

1.29

0.57

1.0

1.1

105.57

97.05

1.00

(40765096) Chromosome analysis panel by Banding

0.57

0.56

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

124

1.37

0.55

2.4

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

242

2249

1.08

0.55

3.7

4.0

13.21

31.56

ug/l

0.51

179

1676

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

307

0.78

0.55

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

303

1.22

0.54

1.2

1.1

—

(3019060) Gas panel - Arterial blood

139

1530

0.91

0.54

6.2

4.9

—

(3034426) Prothrombin time (PT)

169

1.30

0.53

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.50

0.51

2.0

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

794

7664

1.04

0.51

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

251

1.24

0.51

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

251

1.24

0.51

2.8

3.1

8.34

7.83

mg/l

0.14

202

(3016038) Potassium [Moles/volume] in Urine

144

1.32

0.50

1.4

1.2

37.26

35.74

mmol/l

0.11

136

(3007930) Methemoglobin/Hemoglobin.total in Blood

988

0.89

0.50

8.2

5.0

1.01

0.92

0.70

921

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.56

0.49

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

128

1.33

0.47

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

128

1.33

0.47

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

128

1.33

0.47

1.3

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.49

0.47

1.0

2.04

0.24

u/ml

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

267

2509

1.07

0.47

3.9

3.2

1.22

1.23

mmol/l

0.35

235

2170

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

220

1.23

0.43

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

387

1.16

0.42

1.4

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

122

1.31

0.42

3.1

2.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.56

0.42

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

141

1301

1.09

0.42

1.8

2.1

2.87

4.21

iu/l

2.16

541

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.41

0.0

1.9

—

0.14

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.5

—

462.20

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.41

0.0

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

454

1.15

0.41

1.1

1.0

0.59

2.35

u/ml

0.80

113

(3001729) Color of Synovial fluid

0.00

0.40

0.0

1.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

268

1.20

0.40

2.7

2.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.39

0.40

1.1

—

(3024932) HLA-DR beta [Type]

114

1.32

0.40

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

511

1.14

0.40

1.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

511

1.14

0.40

1.9

1.6

—

(3004775) Volume in Urine collected for unspecified duration

194

0.77

0.40

2.0

2.4

727.86

592.71

—

139

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

625

1.12

0.40

3.9

3.3

0.37

0.36

u/ml

0.03

336

(21494890) Protein electrophoresis panel - 24 hour Urine

187

1.23

0.38

2.4

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

513

1.13

0.38

1.8

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

203

1908

1.07

0.38

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

399

0.85

0.38

17.3

13.4

758.79

822.06

nmol/l

0.42

384

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

124

1.29

0.38

2.4

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

124

1.29

0.38

2.4

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.39

0.38

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

236

0.80

0.38

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

206

1.21

0.37

1.1

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

987

0.91

0.37

8.0

4.9

1.68

1.71

0.09

921

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

267

0.82

0.36

1.1

90.13

91.04

0.05

215

(3008757) Leukocyte morphology finding [Identifier] in Blood

300

1.17

0.36

3.1

3.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

574

1.12

0.35

3.7

3.0

32.09

34.03

umol/l

0.41

536

(3016502) Oxygen saturation in Arterial blood

255

2427

1.05

0.34

9.8

8.3

96.41

96.34

0.08

246

2334

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

154

1.23

0.33

2.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

154

1.23

0.33

2.4

1.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

237

1.18

0.33

1.6

1.9

1.67

2.16

u/field

0.24

125

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

285

0.84

0.32

1.4

1.6

—

(3047181) Lactate [Moles/volume] in Blood

893

0.92

0.31

8.6

5.3

1.15

1.23

mmol/l

0.51

788

(3020891) Body temperature

104

964

1.08

0.31

3.8

4.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.33

0.30

7.4

4.9

24.61

24.54

mmol/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

525

0.89

0.29

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

334

0.87

0.28

1.0

315.96

295.29

mg/l

0.23

305

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

131

1232

1.06

0.28

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

441

1.11

0.27

1.1

1.0

2.53

1.28

u/ml

0.34

148

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

720

0.92

0.27

1.6

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

271

1.14

0.27

1.8

2.7

51.57

53.47

0.20

241

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

196

1.17

0.27

1.0

1.2

109.58

97.68

1.18

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

243

1.15

0.26

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

385

1.12

0.26

1.2

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

1.19

0.26

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

216

1.16

0.25

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

151

1.19

0.25

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

695

0.92

0.25

4.0

2.3

0.75

0.85

nmol/l

0.71

600

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

349

1.12

0.25

1.3

1.1

—

(3016750) Collection duration of Urine

159

0.82

0.24

2.3

507.29

508.79

min

—

122

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

219

2283

0.96

0.24

1.9

2.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

240

2307

1.04

0.24

10.3

8.6

122.16

123.11

g/l

0.33

232

2245

(3015076) Soybean IgE Ab [Units/volume] in Serum

436

1.10

0.24

1.1

1.0

0.79

0.39

u/ml

0.65

109

(3013637) Mi-2 Ab [Presence] in Serum

0.71

0.24

1.3

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.71

0.24

1.3

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.71

0.24

1.3

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.71

0.24

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

124

1.21

0.24

1.1

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

124

1.21

0.24

1.1

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

322

1.12

0.23

1.1

1479.73

1477.74

miu/ml

0.00

322

(3000285) Sodium [Moles/volume] in Blood

1.32

0.23

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.24

0.22

1.2

1.1

—

56.00

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.76

0.22

3.1

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.76

0.22

3.1

3.0

—

(3042733) HLA Ab [Presence] in Serum

116

1.21

0.22

3.8

4.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

210

1.14

0.21

1.0

1.1

0.37

3.46

u/ml

2.05

126

(3011897) Casein IgE Ab [Units/volume] in Serum

107

1.22

0.21

1.5

1.1

0.97

0.28

u/ml

0.34

107

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.19

0.21

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

3.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

2.58

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

3.8

—

(40768806) Pleura Pathology biopsy report

154

1.17

0.21

1.4

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

521

5095

1.03

0.20

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1047

0.94

0.20

1.3

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

206.50

—

(4034850) Laboratory test

114

1197

0.95

0.19

6.6

7.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.15

0.19

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.15

0.19

1.2

1.3

—

6.09

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.21

0.18

1.0

13.16

21.09

u/ml

—

(40768441) Liver Pathology biopsy report

271

1.11

0.18

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

252

1.11

0.17

2.1

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

252

1.11

0.17

2.1

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

252

1.11

0.17

2.1

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

358

1.09

0.17

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

358

1.09

0.17

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

866

0.95

0.17

2.0

1.43

1.87

ug/l

0.23

774

(3000012) Reticulocyte production index

299

0.90

0.17

3.2

2.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.76

0.17

11.4

4.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.75

0.17

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

129

1.16

0.17

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

142

1366

1.04

0.16

2.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

408

1.08

0.16

4.8

3.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

149

1.14

0.15

1.1

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

115

1103

1.04

0.15

3.3

3.2

24.85

25.16

mmol/l

0.76

109

1064

(3013293) Extractable nuclear Ab [Presence] in Serum

1.21

0.15

3.0

1.6

—

(3015183) Erythrocyte sedimentation rate

359

0.92

0.15

1.2

—

(3014271) Vancomycin [Susceptibility]

1.10

0.15

3.9

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

169

1.12

0.14

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

822

1.05

0.14

3.9

3.7

47.60

1696.04

u/ml

0.75

695

(3020491) Glucose [Moles/volume] in Blood

355

0.93

0.12

2.3

1.6

6.21

5.88

mmol/l

0.38

282

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

152

1.12

0.12

1.1

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

152

1.12

0.12

1.2

1.6

—

(40768795) Lymph node Pathology biopsy report

307

1.08

0.12

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

356

1.07

0.11

1.3

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

162

1.11

0.11

1.5

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

124

1.13

0.11

4.6

2.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

524

1.05

0.10

1.3

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

388

1.06

0.10

1.2

1.3

—

(4281824) Cell count and differential, peritoneal fluid

369

1.06

0.09

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.04

0.09

1.0

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.04

0.09

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.11

0.09

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

165

1.09

0.08

1.1

60.73

48.13

u/ml

0.37

160

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

257

0.93

0.08

6.4

7.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.03

0.08

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.82

0.08

1.4

9.32

13.13

g/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.83

0.08

1.0

1.1

3.74

10.16

u/ml

—

(3044007) Cell count panel - Peritoneal fluid

0.79

0.08

2.4

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.77

0.08

1.0

7.8

—

(3020650) Glucose [Presence] in Urine

147

1.09

0.07

1.2

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

204

0.93

0.07

1.4

1.6

1.85

4.19

u/field

0.65

152

(3047189) Immunofixation for 24 hour Urine

1.05

0.07

2.9

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

630

1.03

0.06

3.7

3.5

—

(3004451) EKG impression Narrative

1.11

0.06

1.3

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

207

1.06

0.06

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

188

1.06

0.05

1.5

1.3

148.10

164.98

mmol/24h

0.51

188

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

436

1.03

0.04

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

150

1.07

0.04

1.2

1.6

—

(3017569) Oxygen content in Arterial blood

101

1.09

0.04

1.4

2.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

392

0.97

0.04

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

0.92

0.03

2.4

1.5

10.48

8.23

ug/l

0.72

119

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

102

1.08

0.03

1.6

2.9

140.60

109.70

ng/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

380

0.97

0.02

2.3

3.1

—

(3001556) Androgen free Index in Serum or Plasma

128

0.94

0.02

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

168

0.95

0.02

1.2

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

278

0.97

0.02

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

117

0.94

0.01

5.6

6.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

117

0.94

0.01

2.8

3.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

123

1.06

0.01

1.4

2.8

—

(40768446) Kidney Pathology biopsy report

137

0.95

0.01

1.7

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

512

1.02

0.01

1.8

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

268

1.01

0.00

1.4

1.3

68.33

71.99

umol/l

0.58

268

(3005082) Progesterone [Moles/volume] in Serum or Plasma

795

1.01

0.00

1.4

33.12

32.40

nmol/l

0.07

728

(3043410) Blood group antigens tested for on Red Blood Cells

126

1.03

0.00

1.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

107

1.03

0.00

3.3

3.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

4.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.5

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.9

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.93

0.00

1.3

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.94

0.00

1.2

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.36

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.99

-0.00

1.1

1.4

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.87

-0.00

1.2

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.96

-0.00

5.2

2.5

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.96

-0.00

1.6

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.6

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.0

—

2.20

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.99

-0.00

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

7.8

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3033799) Differential panel - Peritoneal fluid

0.92

-0.00

2.0

1.9

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

3.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.93

-0.00

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.97

-0.00

1.4

1.5

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

6.0

—

0.53

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

312.17

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

440

1.00

-0.00

1.3

1.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

234.62

—

(3035880) pH of Pleural fluid

0.91

-0.00

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.90

-0.00

1.2

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_ANOGENITAL_HERPES_SIMPLEX_WIDE – Anogenital herpesviral [herpes simplex] infection

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Anogenital herpesviral [herpes simplex] infection

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Anogenital herpesviral [herpes simplex] infection (AB1_ANOGENITAL_HERPES_SIMPLEX_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints